rfhg_8369.1

Basic information about the TSS

---

TSS ID: rfhg_8369.1 Species: human Chr: chr1		Start: 77979231 End: 77979252 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2186198,EH38E1360810)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000477671.2:0 AK297985:0 GeneID: 11080 HGNC/MGI_ID: HGNC:14886 UniProt_ID: Nearer transcript ids and distances: LF206371:20 MA441948:20 LF213876:24 MA449453:24 ENST00000484662.1:29 ENST00000487931.1:-56 NM_001317102.2:-56 NM_001317101.2:-56 NM_001317100.2:-56 LF383513:-83 MA619090:-83 LF353613:-199 MA589190:-199 ENST00000476882.1:290 view more...

Gene_name: DnaJ heat shock protein family (Hsp40) member B4 Gene_symbol: DNAJB4 Gene_synonyms: HLJ1 Gene_source: HGNC:14886

TATA-Box annotation

---

Distance to TSS:	-36
Nearest PromoterID:	NM_001303433
Entrez ID:	8880
Nearest Unigene:	Hs.567380
Nearest Refseq:	NM_003902
Nearest Ensembl:	ENSG00000162613
Gene Name:	DnaJ heat shock protein family (Hsp40) member B4
Gene Alias:	FBP|FUBP|hDH V
Gene Type:	protein-coding
CpG%:	0.095238
GC%:	0.363636
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DNAJB4 p2@DNAJB4 p4@DNAJB4 p5@DNAJB4 p6@DNAJB4 p7@DNAJB4 p8@DNAJB4 p9@DNAJB4 p10@DNAJB4
Sample		p1@DNAJB4	p2@DNAJB4	p4@DNAJB4	p5@DNAJB4	p6@DNAJB4	p7@DNAJB4	p8@DNAJB4	p9@DNAJB4	p10@DNAJB4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	3.90	1.56	3.51	2.34	0.97	0.00	0.00	0.78	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	6.07	0.61	3.24	0.81	0.40	0.61	0.00	0.40	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	3.67	0.96	4.24	1.74	1.16	0.00	0.00	0.39	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	2.29	0.00	4.78	1.25	1.46	0.00	0.00	0.62	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	2.92	0.45	5.62	1.12	1.80	0.67	0.00	0.45	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	4.26	1.16	5.04	0.78	1.74	0.19	0.00	0.19	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	6.32	1.96	3.27	1.53	1.96	0.22	0.00	1.09	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	4.12	0.97	5.81	2.42	1.45	0.00	0.24	0.48	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	2.56	1.50	2.99	1.07	1.71	0.00	0.00	1.50	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	6.38	0.58	3.48	1.16	1.16	0.00	0.00	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	6.47	0.40	3.23	0.81	0.40	0.00	0.00	1.62	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	6.91	1.22	5.29	0.81	0.41	1.63	0.00	1.22	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	16.93	3.55	0.64	3.22	1.13	1.93	0.48	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	19.09	4.96	1.95	3.16	0.75	1.80	0.15	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	18.88	4.61	1.32	4.83	1.54	1.76	0.44	0.66	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	15.84	3.02	1.26	2.26	0.50	1.51	1.51	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	22.06	4.80	1.09	2.62	1.75	1.09	0.44	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	15.61	5.48	0.00	3.37	1.27	0.84	0.84	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	18.13	3.73	0.00	4.27	1.07	1.07	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	23.17	4.21	1.05	4.06	0.75	1.96	0.90	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	18.58	4.01	1.47	3.34	1.34	1.34	1.07	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	23.65	5.18	0.86	3.45	0.69	1.21	0.86	0.17	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	22.88	3.88	1.68	2.46	0.39	1.68	0.39	0.52	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	22.08	2.91	2.43	1.46	0.49	1.70	0.24	0.24	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	14.19	5.42	0.52	2.84	0.52	0.52	0.77	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	15.19	4.11	0.63	3.17	0.95	1.27	0.95	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	13.19	2.20	0.55	1.65	1.65	1.10	1.10	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	20.51	5.89	1.18	2.59	1.18	1.65	0.24	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	11.15	4.85	0.97	2.91	0.48	0.32	0.48	0.48	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	18.28	3.44	0.90	2.71	0.54	1.27	0.54	0.36	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	15.91	4.81	0.84	2.09	0.42	1.26	0.21	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	13.87	3.71	0.98	3.32	0.59	0.39	0.20	0.59	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.55	2.32	1.69	2.11	0.63	0.42	0.21	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	23.59	5.11	0.99	3.46	0.82	0.99	0.33	0.82	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	21.50	5.05	0.37	2.99	0.75	0.75	0.37	0.37	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	18.01	2.68	0.96	1.53	0.57	0.96	0.57	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	24.73	5.72	0.82	1.84	1.02	1.64	0.82	0.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	22.77	5.04	1.01	1.01	0.40	1.01	0.20	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	22.42	4.86	0.81	2.97	0.54	1.08	0.54	0.81	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	18.96	5.52	0.24	4.56	1.68	0.24	0.48	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	22.11	4.71	0.71	0.94	0.24	1.65	0.47	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	25.47	3.81	1.76	2.20	0.15	1.32	1.17	0.29	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	34.59	9.70	1.69	1.90	0.63	1.27	1.05	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	24.30	7.17	1.40	2.27	1.05	2.45	0.17	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	28.51	6.83	1.20	4.22	0.80	1.61	0.80	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	27.92	6.98	0.70	1.86	0.47	1.16	0.93	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	22.31	5.52	1.20	2.64	0.96	1.44	1.44	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	24.74	3.58	0.89	2.98	0.89	1.79	0.60	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	20.59	5.51	0.48	1.44	0.72	1.68	0.48	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	22.85	5.66	1.21	2.02	1.01	2.63	0.61	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	35.87	8.40	1.64	1.23	0.82	1.23	1.02	0.20	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	37.58	6.67	1.33	2.00	1.11	2.00	1.56	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1287.28	209.88	41.98	41.98	13.99	69.96	27.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	30.52	7.45	1.06	1.77	0.35	1.06	0.35	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	30.16	7.29	0.66	0.33	0.33	0.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	193.79	36.07	15.94	11.75	4.19	11.75	3.36	2.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	74.86	12.86	1.84	4.59	0.46	1.38	3.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	39.87	5.51	1.94	1.62	0.00	1.62	0.97	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	31.47	2.25	1.61	1.28	0.64	0.32	0.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	95.87	13.52	1.89	3.77	0.94	3.46	2.83	0.94	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	38.07	7.05	1.41	2.12	1.41	0.00	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	40.94	3.93	1.12	2.24	0.00	1.12	0.00	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	144.90	33.44	3.18	7.96	1.59	5.57	2.39	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	68.97	10.19	1.70	3.40	0.00	1.70	1.70	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	45.81	6.50	0.97	2.27	0.32	0.32	0.97	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	45.79	8.16	2.13	3.55	0.71	1.06	1.06	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	2230.62	193.97	16.16	64.66	0.00	80.82	32.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1587.39	315.90	63.18	63.18	15.79	39.49	23.69	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	140.89	15.60	3.90	1.95	0.98	1.46	1.46	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	163.14	17.85	3.47	2.48	0.00	3.47	1.98	1.49	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	157.15	17.36	3.28	3.75	0.94	1.41	1.88	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	400.41	38.75	3.31	3.64	1.32	4.31	3.64	0.66	3.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	253.66	25.68	3.40	2.78	0.31	2.17	2.78	0.31	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	207.29	18.04	3.06	2.75	0.61	3.97	3.36	0.92	1.53
Adipocyte - breast, donor1	11376-118A8	277.17	22.65	6.18	3.33	3.33	2.53	3.01	2.38	0.79
Adipocyte - breast, donor2	11327-117E4	87.75	9.79	2.73	4.49	1.93	1.28	0.80	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	340.33	27.86	7.25	5.98	4.33	2.80	5.34	2.42	1.15
Adipocyte - omental, donor2	11474-119C7	65.03	13.45	2.24	3.74	1.49	1.49	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	53.59	13.06	3.01	4.35	2.68	0.00	0.33	0.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	60.61	10.85	5.10	5.10	1.28	0.64	4.47	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	36.28	4.40	2.20	0.00	0.00	0.00	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	86.26	6.77	2.71	2.26	0.45	0.45	1.35	1.35	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	5.39	2.09	0.87	1.39	0.70	0.17	0.35	0.52	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	16.43	5.08	2.74	2.54	0.78	1.17	1.37	0.59	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	11.07	4.89	1.03	2.32	0.26	1.54	1.29	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	13.10	3.35	2.79	3.07	0.28	0.56	1.12	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	11.17	4.70	1.76	2.94	1.18	1.18	0.59	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	13.11	4.02	3.62	1.85	1.77	0.88	1.21	0.08	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	12.91	3.87	0.97	1.61	0.97	0.97	0.97	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	15.46	2.67	2.13	1.07	2.67	0.53	0.53	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	12.80	1.67	1.67	0.56	0.56	1.11	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	4.57	0.83	2.08	1.25	1.66	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	8.29	3.27	0.25	0.50	1.00	0.50	1.26	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	9.16	0.65	2.95	1.31	1.31	0.33	0.33	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	9.74	2.74	1.22	0.61	0.61	0.61	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	7.29	1.10	1.10	0.66	0.66	0.44	0.22	0.66	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	0.36	0.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	0.00	0.00	1.20	0.00	0.00	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	18.17	0.90	1.80	0.36	0.54	0.18	0.36	0.54	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	0.00	0.00	0.00	1.67	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	25.68	2.88	1.64	0.82	0.62	0.62	0.21	0.62	0.21
Anulus Pulposus Cell, donor1	11248-116E6	51.49	7.44	1.83	3.89	1.60	1.26	0.46	0.80	0.23
Anulus Pulposus Cell, donor2	11463-119B5	22.29	5.14	0.24	3.18	0.49	0.24	1.22	0.00	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	65.60	10.33	2.70	2.25	0.90	0.00	0.00	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	49.49	5.21	4.78	0.43	1.30	0.00	0.43	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	83.47	6.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	64.27	7.77	2.99	2.09	1.20	1.49	1.79	1.20	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	48.06	12.65	2.53	2.53	0.00	1.26	1.26	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	47.53	7.26	1.32	0.66	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	43.21	5.85	4.55	0.97	0.97	0.97	0.32	0.97	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	58.74	4.85	1.94	1.46	1.46	0.97	0.97	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	71.86	5.34	0.00	1.19	0.59	0.00	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	80.60	13.94	1.51	1.51	0.75	1.51	0.38	2.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	50.80	10.16	0.73	4.35	0.73	0.73	0.73	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	62.69	5.02	1.25	1.25	2.51	0.00	0.00	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	106.58	10.38	3.95	1.98	1.65	0.66	0.99	1.65	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	45.04	8.19	1.36	4.09	1.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	83.99	6.63	2.71	1.36	0.60	1.06	1.06	0.90	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	46.61	8.04	2.68	1.61	0.54	0.00	0.54	0.54	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	57.63	7.37	2.46	1.70	0.38	0.76	1.13	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	78.31	5.61	1.60	2.14	0.53	0.53	0.53	1.34	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	41.94	4.88	2.93	2.93	0.00	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	62.03	6.80	2.49	1.49	1.16	0.33	0.50	1.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	66.04	4.80	1.20	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	49.56	0.00	0.00	3.54	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	51.63	6.69	1.20	1.54	0.51	0.69	0.17	1.37	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	79.70	8.39	0.00	0.00	0.00	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	63.11	10.19	3.40	1.94	0.49	0.97	1.94	1.94	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	86.14	8.35	3.04	1.14	0.38	2.28	0.76	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	65.41	6.06	1.21	1.21	1.21	0.00	1.21	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	70.11	10.83	3.42	0.00	2.28	1.14	0.57	1.14	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	53.66	5.34	2.57	1.50	1.28	0.86	0.43	0.64	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	56.01	3.61	1.29	0.26	1.55	0.26	0.77	0.77	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	47.86	7.04	2.35	1.88	0.47	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	53.06	5.47	2.57	1.29	1.29	0.32	0.32	0.96	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	62.78	3.57	4.28	1.43	0.71	0.00	0.00	1.43	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	46.80	3.51	3.51	2.34	0.58	0.58	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	59.61	6.62	3.01	2.11	0.60	0.90	0.30	1.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	74.84	10.69	2.38	0.00	1.19	0.00	1.19	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	77.30	9.15	5.09	2.54	1.02	1.53	0.51	1.53	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	73.86	10.19	2.80	1.02	0.51	0.25	1.02	1.53	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	41.30	5.72	0.64	0.00	0.00	0.00	0.64	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	54.37	5.18	3.88	0.86	0.43	1.29	0.43	0.86	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	77.05	8.04	1.69	1.91	1.06	1.48	0.64	1.69	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	64.96	6.67	2.32	1.16	0.58	0.29	0.58	0.58	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	53.85	4.72	0.94	2.83	0.00	1.89	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	58.66	5.76	2.54	1.86	1.36	1.02	0.34	1.53	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	69.49	2.32	2.32	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	65.49	8.45	0.00	4.23	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	46.74	5.36	2.14	2.36	0.43	0.64	0.21	1.07	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	68.59	2.41	1.20	1.20	0.60	0.60	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	50.30	4.37	2.19	1.46	0.73	0.00	0.73	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	54.25	5.98	2.76	0.69	0.69	1.61	1.15	0.92	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	73.96	7.65	5.10	0.00	2.55	0.00	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	126.35	10.17	2.29	1.02	1.27	0.76	0.25	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	53.05	4.95	2.48	2.48	0.41	0.62	0.62	0.62	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	53.55	6.43	1.22	1.84	2.14	0.31	0.00	0.61	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	69.31	9.56	2.87	0.96	0.48	0.96	0.48	1.91	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	48.56	4.43	1.77	1.33	0.44	0.44	0.44	1.11	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	65.61	6.10	3.05	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	45.97	5.54	2.22	2.77	0.55	0.55	0.00	1.66	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	50.84	7.68	2.91	1.06	0.79	0.26	0.26	1.06	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	52.34	5.45	2.54	1.82	1.09	0.36	0.73	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	10.56	2.70	0.61	4.05	0.12	0.12	0.86	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	8.90	2.05	0.51	3.59	0.17	0.34	0.17	0.17	0.17
Astrocyte - cerebellum, donor3	11661-122F5	1.89	0.42	0.00	1.68	0.00	0.42	0.42	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	9.76	3.83	3.49	5.23	2.44	1.05	0.70	1.05	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	6.47	1.78	1.94	5.18	1.62	0.32	0.32	2.10	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	16.86	3.43	2.09	4.18	0.75	1.34	0.30	1.34	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	21.90	5.05	1.15	2.18	0.34	0.57	0.80	1.15	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	15.53	6.39	1.00	1.50	0.75	0.75	0.13	0.25	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	14.11	3.30	0.34	2.73	0.11	0.34	0.46	0.23	0.00
Basophils, donor1	12241-129G9	11.77	3.66	1.05	2.09	0.00	0.78	0.26	0.00	0.26
Basophils, donor2	12242-129H1	27.06	10.10	0.72	2.16	0.72	0.72	4.69	1.44	0.36
Basophils, donor3	12243-129H2	11.76	3.82	0.15	0.29	0.15	0.73	0.73	0.29	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	1.51	1.51	0.00	1.51	0.00	0.22	0.00	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	0.00	0.00	0.00	0.91	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	3.77	0.63	2.51	0.00	0.63	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	1.15	0.69	0.23	0.23	0.23	0.00	0.00	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	16.73	2.34	1.44	2.70	1.08	1.26	0.36	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	15.66	2.99	1.03	4.23	0.82	1.13	0.72	1.03	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	32.84	7.69	1.63	4.66	0.47	1.40	0.70	0.00	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	10.87	4.80	0.96	2.88	0.32	0.32	0.00	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	0.00	0.00	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	79.46	21.42	0.00	0.00	0.00	2.25	2.25	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	25.43	14.85	0.74	1.48	0.37	0.74	0.37	0.00	0.19
CD14+ Monocytes, donor3	11381-118B4	20.86	10.10	1.54	1.76	0.22	0.66	0.22	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	19.81	5.66	1.70	4.25	1.98	0.85	3.40	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	17.82	5.69	2.27	3.03	1.14	0.76	0.76	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	18.08	8.88	1.31	1.97	1.64	0.99	1.97	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	23.71	4.05	6.79	1.01	1.59	1.73	0.58	0.43	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	54.92	6.34	6.03	0.60	0.60	2.41	1.81	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	42.40	5.69	3.55	0.47	1.66	0.24	0.71	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	50.55	11.05	3.68	1.00	1.51	0.67	2.01	0.17	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	98.81	17.94	6.35	0.83	1.10	2.76	1.38	0.83	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	148.51	26.53	7.69	1.24	1.49	4.71	3.47	0.74	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	45.23	6.66	2.94	0.78	0.59	1.57	0.78	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	48.61	9.61	6.23	0.71	0.89	2.67	1.96	0.36	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	129.49	16.54	6.75	1.52	0.87	1.52	1.74	0.44	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	177.00	21.31	2.58	0.23	0.70	3.04	2.81	0.00	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	255.04	28.51	7.92	0.53	2.11	6.34	0.53	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	163.08	16.64	8.87	0.00	1.11	3.33	4.44	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	34.06	6.69	3.27	1.49	0.30	1.78	1.93	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	111.35	12.77	5.79	1.20	1.60	1.80	1.40	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	185.92	20.61	8.95	1.67	2.08	4.58	3.33	0.42	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	272.25	25.17	3.89	0.46	0.46	2.06	2.06	0.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	521.85	32.80	8.37	0.68	0.68	3.39	3.85	0.68	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	259.26	19.20	3.06	1.31	0.87	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	69.13	9.41	4.84	0.54	1.08	1.61	1.34	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	45.36	10.29	4.36	0.70	0.87	2.44	0.70	0.87	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	63.54	10.10	3.79	0.42	0.84	1.68	1.26	2.10	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	247.46	30.86	3.49	0.73	0.55	3.49	2.94	0.37	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	371.29	33.47	5.99	1.41	1.06	2.47	3.17	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	322.46	39.05	7.90	0.44	1.32	6.14	5.70	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	40.98	9.59	4.36	0.87	1.57	4.18	0.87	0.52	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	38.65	6.32	4.46	0.37	1.12	3.35	2.23	1.86	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	115.32	16.81	7.76	1.72	2.16	3.23	1.72	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	214.98	21.29	2.46	0.41	1.23	3.69	2.87	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	670.13	57.25	9.27	0.70	0.23	6.03	3.94	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	740.29	59.16	6.50	0.93	0.93	6.03	6.50	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	4.80	2.18	0.44	0.44	0.44	0.00	0.22	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	17.32	5.54	0.92	2.08	0.69	0.69	0.46	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	9.96	1.73	1.08	0.65	0.22	0.00	1.52	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	4.20	1.40	0.62	1.71	0.62	0.31	0.16	0.31	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	5.41	2.79	1.40	0.87	0.17	0.17	0.52	0.17	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	11.59	4.91	2.01	0.89	0.22	1.11	0.89	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	3.06	1.79	2.30	1.79	0.26	0.00	0.26	0.51	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	5.27	2.63	1.10	0.66	0.00	0.22	0.22	0.44	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	7.58	3.79	1.89	1.05	0.42	1.05	0.00	0.84	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	2.03	4.06	8.13	2.03	2.03	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	3.39	1.36	2.71	6.78	4.07	2.71	0.68	2.71	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	2.07	1.04	1.04	2.07	5.18	4.14	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	8.00	2.13	3.20	6.40	2.13	1.60	0.53	0.53	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	3.75	2.68	2.68	10.19	2.14	2.68	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	11.93	4.91	2.81	7.02	0.70	0.70	0.70	0.70	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	5.49	0.78	5.49	4.71	1.57	1.57	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	5.27	11.86	2.64	6.59	3.95	3.95	1.32	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	11.51	6.58	0.82	2.47	0.00	0.00	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	13.78	3.63	0.73	1.45	1.45	0.73	0.73	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	13.63	4.54	0.00	1.01	0.00	0.00	1.01	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	283.65	29.50	12.93	2.42	4.85	3.23	1.62	2.42	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	215.73	27.17	11.19	3.20	2.00	0.80	2.80	0.40	0.80
CD34+ Progenitors, donor1	11545-120B6	9.04	5.02	1.00	4.02	0.00	2.01	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	25.28	11.24	1.12	1.12	0.56	0.56	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	9.02	4.88	1.88	1.50	1.50	0.75	0.75	1.13	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	13.75	3.38	1.35	0.90	1.13	0.23	0.45	1.13	0.23
CD4+ T Cells, donor1	11225-116C1	33.92	8.93	1.43	3.93	0.36	1.07	1.07	0.36	2.14
CD4+ T Cells, donor2	11306-117C1	11.02	2.45	0.61	3.06	0.00	0.00	0.61	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	6.10	2.74	0.30	3.05	0.00	0.61	0.30	0.30	3.05
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	4.34	3.83	1.02	5.10	0.26	0.26	0.26	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	7.64	2.02	1.35	2.47	0.67	1.57	0.90	0.00	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	8.34	2.01	0.86	3.45	0.00	1.15	0.57	0.57	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	15.17	6.16	1.42	6.16	0.47	0.95	0.95	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	18.26	6.32	0.00	6.32	0.00	1.40	1.40	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	13.18	3.30	0.00	0.00	0.00	0.00	0.00	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	6.07	1.59	0.58	1.88	0.72	0.87	0.29	0.87	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	7.12	2.54	0.51	0.68	0.00	0.00	0.00	0.34	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	9.67	3.22	0.81	1.29	0.32	0.81	0.64	0.48	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	19.73	6.28	1.34	2.24	0.00	0.45	0.00	0.45	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	32.84	12.93	0.35	4.89	0.00	3.49	2.10	0.70	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	39.60	14.52	0.44	4.40	2.20	1.32	2.20	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	10.12	2.53	0.84	2.53	0.00	0.42	0.84	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	6.44	1.87	0.42	2.29	0.21	0.21	0.42	0.21	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	6.01	1.00	0.33	2.67	0.33	0.00	0.00	0.67	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	19.85	7.89	2.72	5.17	1.09	0.54	0.54	0.27	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	20.90	8.58	2.14	6.97	0.54	1.61	0.54	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	10.76	7.17	0.00	0.00	0.00	0.00	1.79	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	4.64	1.30	1.11	2.60	0.56	0.00	0.37	0.37	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	3.90	1.95	0.87	1.95	0.43	0.22	0.43	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	11.14	2.94	1.05	3.78	0.21	0.63	0.63	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	11.63	3.03	0.51	4.55	0.51	0.00	0.00	0.00	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	12.13	8.23	0.87	4.33	0.43	0.00	0.43	0.87	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	28.33	7.84	1.74	5.23	2.18	0.87	1.31	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	9.40	1.98	0.49	4.45	1.98	2.47	0.99	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	9.23	1.85	0.00	2.77	0.92	2.77	0.92	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	9.77	8.37	0.00	6.98	0.00	0.00	0.00	0.00	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	8.86	4.43	2.77	7.75	2.22	1.94	1.66	0.55	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	9.57	4.91	3.68	6.38	1.47	1.72	1.23	0.49	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	10.78	3.08	0.00	6.16	1.54	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	10.39	1.43	2.86	5.01	0.72	1.07	0.36	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	5.54	4.15	1.38	6.92	1.38	1.38	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	37.00	9.82	0.65	3.60	0.33	1.64	0.33	0.00	1.31
CD8+ T Cells, donor2	11307-117C2	11.26	3.38	1.13	3.75	0.00	0.75	1.13	0.00	1.88
CD8+ T Cells, donor3	11383-118B6	13.38	4.80	1.26	4.80	0.25	0.25	0.25	0.00	2.02
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	7.80	1.38	1.38	1.84	0.23	0.00	0.00	0.92	1.38
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	7.91	2.16	1.92	0.72	0.72	0.24	0.00	0.96	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	13.13	1.92	0.82	1.64	0.55	0.27	0.27	0.27	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	14.71	2.70	1.80	2.10	0.60	0.30	0.00	0.30	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	9.12	1.20	1.20	1.68	0.96	0.24	0.00	0.24	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	11.60	1.82	1.14	0.45	0.68	0.00	0.23	0.68	1.59
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	10.43	2.39	1.52	1.96	0.65	0.00	0.00	0.43	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	13.42	2.37	0.53	1.58	0.53	0.00	0.26	0.79	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	10.32	2.11	1.88	2.11	0.70	0.23	0.47	0.47	1.64
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	13.89	2.11	1.81	1.81	0.60	0.00	0.00	0.60	2.11
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	12.20	2.32	1.16	1.16	1.45	0.00	0.00	0.58	2.03
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	11.19	1.60	2.13	2.13	0.80	0.00	0.00	0.00	1.87
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	66.98	7.00	9.19	2.19	5.25	0.44	0.44	1.31	4.82
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	75.60	4.10	6.38	1.37	2.28	0.46	0.46	0.00	2.73
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	91.00	8.20	2.98	0.75	1.49	0.00	1.49	0.00	3.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	12.25	0.72	3.96	1.44	1.08	0.00	0.36	0.00	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	13.52	1.44	2.01	1.73	2.30	0.29	0.00	1.15	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	9.43	1.18	1.65	0.94	1.18	0.00	0.47	0.47	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	17.43	4.12	3.80	3.80	1.27	0.00	0.00	1.27	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	14.15	3.08	3.38	2.15	1.85	0.00	0.31	0.62	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	16.35	3.21	4.17	3.53	1.28	0.00	0.00	0.64	2.56
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	19.12	4.21	1.91	3.44	1.91	0.00	0.38	1.15	2.29
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	19.71	3.55	2.36	3.55	1.58	0.00	0.39	1.18	2.36
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	19.67	1.51	1.51	3.03	0.00	0.00	0.00	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	96.35	8.03	8.03	6.42	4.82	0.00	0.80	0.80	6.42
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	110.51	10.49	6.99	9.09	1.40	0.00	0.70	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	132.23	12.02	11.02	3.01	4.01	0.00	0.00	2.00	8.01
Cardiac Myocyte, donor1	11525-119I4	113.32	10.97	1.83	1.83	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	19.76	3.46	1.48	0.99	0.00	0.00	0.00	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	46.30	6.21	2.63	1.58	0.84	1.79	0.95	0.63	0.11
Chondrocyte - de diff, donor1	11261-116G1	54.08	11.09	1.04	1.04	0.35	1.73	1.39	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	30.56	7.11	1.07	1.78	1.42	1.07	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	36.75	6.37	2.16	1.25	1.59	0.91	0.34	0.57	0.11
Chondrocyte - re diff, donor2	11339-117F7	28.65	8.06	0.90	0.90	0.00	0.00	0.90	2.69	0.00
Chondrocyte - re diff, donor3	11411-118E7	12.54	3.64	0.40	3.24	0.81	1.21	0.81	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	31.44	9.75	2.30	3.33	1.61	2.18	1.03	1.84	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	26.51	5.34	0.86	3.63	0.86	1.92	1.07	0.86	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	17.08	5.49	0.88	3.19	0.71	1.06	0.18	0.80	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	36.59	5.87	3.94	3.30	3.21	2.11	1.83	1.38	0.09
Corneal Epithelial Cells, donor1	11526-119I5	0.88	0.44	0.00	0.22	0.22	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	2.28	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	0.77	0.00	0.00	0.26	0.00	0.26	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	29.88	5.45	1.16	2.31	1.16	0.99	0.66	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	26.18	4.73	1.58	2.84	1.26	0.63	1.26	0.95	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	3.45	3.45	0.00	0.00	0.00	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	6.91	1.19	1.51	1.62	0.65	0.00	0.43	0.54	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	40.31	8.88	0.34	0.00	0.00	1.02	0.68	0.68	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	25.46	9.79	0.00	2.61	0.00	0.65	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	17.91	11.13	0.00	2.90	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	74.21	5.50	2.33	2.84	0.00	0.83	0.17	0.67	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	31.10	1.17	1.17	1.76	0.59	0.00	0.00	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	102.37	7.35	1.41	3.11	1.13	1.41	1.13	0.28	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	89.25	6.68	1.57	3.15	1.18	1.18	1.18	0.00	1.18
Endothelial Cells - Artery, donor1	11264-116G4	74.46	6.40	1.45	2.04	0.87	0.00	0.58	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	74.82	7.06	1.18	0.71	0.71	0.94	0.71	0.24	0.47
Endothelial Cells - Artery, donor3	11413-118E9	34.71	3.68	2.10	1.75	0.35	0.53	0.18	0.53	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	118.81	8.64	5.76	3.32	2.66	1.77	0.22	1.55	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	107.71	9.43	5.17	8.52	2.74	2.43	2.74	0.91	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	145.74	14.38	4.79	3.10	3.66	2.54	2.26	1.69	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	73.99	10.10	1.19	1.19	0.59	0.00	0.59	0.59	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	98.41	9.37	1.56	1.04	0.52	1.56	1.04	1.04	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	34.45	4.54	2.69	1.42	0.71	0.85	0.14	0.71	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	340.50	34.41	9.60	4.00	1.60	0.40	4.80	0.80	2.00
Endothelial Cells - Thoracic, donor2	11343-117G2	35.64	1.05	1.57	2.10	0.00	1.05	0.52	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	350.13	31.81	7.70	10.44	3.48	9.07	2.61	2.73	2.48
Endothelial Cells - Umbilical vein, donor2	11324-117E1	135.14	19.34	3.48	6.52	0.65	3.69	1.09	1.09	1.96
Endothelial Cells - Umbilical vein, donor3	11400-118D5	127.99	12.95	4.15	5.86	1.47	2.08	1.71	1.34	1.47
Endothelial Cells - Vein, donor1	11267-116G7	20.48	2.28	2.28	1.14	1.14	0.00	0.00	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	19.56	1.40	0.70	2.10	1.40	0.00	0.00	0.70	0.70
Endothelial Cells - Vein, donor3	11416-118F3	27.63	4.24	1.41	2.98	0.31	0.63	0.47	0.16	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	13.20	3.30	1.65	1.65	0.00	0.00	0.00	0.00	1.65
Eosinophils, donor3	12246-129H5	24.97	7.13	0.00	3.57	0.00	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	1.47	0.49	0.00	0.49	0.24	0.24	0.00	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	2.08	0.00	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	116.59	16.01	2.46	1.64	1.64	2.46	2.87	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	83.76	6.68	1.75	1.09	0.77	0.99	1.31	0.77	0.55
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	17.33	2.60	1.95	1.30	0.22	0.33	0.87	0.54	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	85.50	11.28	2.43	4.24	1.21	1.70	0.97	2.30	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	531.01	33.16	2.87	14.33	2.46	3.96	2.32	2.32	4.50
Fibroblast - Aortic Adventitial, donor2	11326-117E3	38.29	5.27	1.48	2.53	0.74	0.42	0.32	0.53	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	54.81	10.28	1.05	11.86	0.53	0.53	1.32	0.53	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	28.57	6.98	0.66	1.99	0.66	1.33	0.66	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	20.41	1.81	1.81	1.36	0.45	0.45	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	13.64	0.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	24.13	3.31	1.26	0.79	0.47	1.26	0.79	0.16	0.32
Fibroblast - Cardiac, donor4	11452-119A3	148.22	14.55	5.15	5.76	3.64	4.55	1.82	1.82	1.52
Fibroblast - Cardiac, donor5	11456-119A7	69.54	9.90	2.92	6.47	1.40	1.14	0.51	1.14	1.14
Fibroblast - Cardiac, donor6	11460-119B2	78.22	10.61	2.88	4.09	0.30	1.06	1.06	0.61	0.91
Fibroblast - Choroid Plexus, donor1	11492-119E7	37.65	6.43	0.67	3.08	0.27	0.54	0.94	0.13	0.67
Fibroblast - Choroid Plexus, donor2	11572-120E6	66.44	7.33	0.43	2.16	0.86	0.86	0.43	1.29	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	64.45	10.25	2.93	1.46	0.00	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	13.84	2.77	0.23	2.08	0.23	0.69	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	40.37	5.26	3.56	3.22	3.05	0.85	0.68	1.36	0.17
Fibroblast - Dermal, donor1	11269-116G9	13.85	3.05	1.41	1.64	0.47	0.47	0.23	0.23	0.47
Fibroblast - Dermal, donor2	11346-117G5	21.70	3.77	0.47	1.89	0.47	0.47	0.00	0.00	0.94
Fibroblast - Dermal, donor3	11418-118F5	33.24	4.84	1.93	1.45	0.73	0.48	0.24	0.60	0.36
Fibroblast - Dermal, donor4	11450-119A1	54.71	9.16	1.36	6.33	0.11	1.02	0.68	0.45	0.34
Fibroblast - Dermal, donor5	11454-119A5	61.23	13.96	2.79	4.54	0.52	0.87	0.87	0.35	1.05
Fibroblast - Dermal, donor6	11458-119A9	95.18	15.43	2.60	4.39	0.81	1.62	1.30	0.16	0.32
Fibroblast - Gingival, donor1	11237-116D4	67.05	8.75	4.16	4.16	2.08	0.83	0.83	2.29	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	23.06	4.72	1.57	3.41	0.79	0.52	0.26	1.31	0.00
Fibroblast - Gingival, donor2	11318-117D4	15.29	1.98	1.45	7.38	1.45	0.40	0.00	0.79	0.26
Fibroblast - Gingival, donor3	11394-118C8	22.04	2.90	2.13	4.06	1.06	1.16	0.00	1.26	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	31.17	0.00	1.04	5.19	1.04	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	10.92	2.64	1.06	1.59	0.53	0.00	0.53	0.53	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	26.35	4.83	4.21	1.09	1.25	0.94	0.16	0.62	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	17.44	3.52	2.30	1.76	1.22	0.54	0.27	1.08	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	18.70	2.47	1.41	1.06	0.35	0.71	0.00	0.00	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	44.31	8.77	2.05	3.07	1.17	1.02	0.44	1.17	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	36.95	7.50	3.55	2.45	0.68	0.55	0.41	0.95	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	50.13	8.34	3.73	3.07	1.10	0.44	0.55	0.88	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	14.38	4.26	3.52	4.26	2.49	0.88	0.00	1.61	0.44
Fibroblast - Lung, donor1	11270-116H1	4.08	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	38.80	7.46	4.48	5.97	1.49	0.00	0.00	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	6.75	1.27	1.90	2.74	1.27	0.00	0.00	0.21	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	109.96	10.83	1.67	2.50	0.83	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	47.55	5.59	0.00	2.80	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	19.59	1.40	0.28	0.28	0.28	0.00	0.00	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	133.16	11.77	2.44	5.28	0.41	2.03	2.84	0.41	1.22
Fibroblast - Mammary, donor2	11620-122A9	47.93	7.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	101.26	0.00	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	15.71	2.33	2.72	5.43	1.36	0.00	0.58	0.58	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	14.26	2.73	1.52	3.94	1.21	0.61	0.30	0.46	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	166.15	14.38	4.90	4.90	3.98	2.75	1.84	2.14	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	42.36	9.16	4.20	3.82	1.53	0.76	0.76	1.14	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	36.45	6.21	0.81	2.16	1.08	0.27	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	18.90	4.29	2.55	1.97	1.39	0.35	0.70	0.35	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	123.02	13.26	5.20	0.99	3.21	1.44	0.99	1.22	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	17.07	2.84	1.02	0.81	0.00	0.61	0.81	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	7.35	0.00	0.00	0.67	0.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	31.23	4.74	1.98	1.58	0.79	0.79	0.40	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	142.68	25.80	1.59	8.93	1.39	0.79	1.19	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	52.75	7.10	2.31	3.02	1.24	1.42	1.24	0.71	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	118.45	13.60	5.12	5.52	2.96	1.18	1.18	0.59	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	114.02	21.06	2.41	5.72	1.20	0.00	1.20	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	92.30	16.73	5.18	3.99	2.05	1.19	1.40	0.54	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	93.13	16.45	1.27	9.87	0.76	0.51	1.01	0.76	0.51
Fibroblast - skin normal, donor1	11553-120C5	67.76	7.06	1.97	1.15	0.82	0.82	0.82	1.48	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	407.23	34.09	2.81	7.02	1.40	4.81	2.41	1.40	0.80
Fibroblast - skin normal, donor2	11561-120D4	63.99	11.75	3.21	3.01	1.41	0.80	1.51	0.90	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	121.20	27.20	2.42	6.95	1.51	0.30	2.72	0.30	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	79.45	9.69	5.72	3.73	2.90	1.49	1.41	1.16	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	72.14	12.48	3.42	9.57	1.88	0.51	1.88	0.34	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	68.97	19.05	1.64	7.23	0.99	0.00	1.31	0.99	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	69.45	16.40	3.83	2.34	1.38	1.17	1.17	1.28	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	56.17	6.24	4.05	2.02	0.84	1.18	0.84	0.67	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	53.63	8.00	4.70	1.41	2.04	0.94	0.47	0.63	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	4919.47	421.04	44.32	0.00	66.48	110.80	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	9.59	3.49	1.74	1.74	0.00	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	9.01	2.25	4.85	1.56	2.77	0.52	0.52	1.56	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	19.78	2.60	4.42	0.78	2.34	0.26	0.52	2.34	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	6.13	3.32	3.58	3.32	3.58	0.00	0.00	1.02	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	0.77	0.00	0.77	2.30	0.00	0.77	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	0.00	0.00	1.91	1.28	1.91	0.00	0.00	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	2.28	0.86	1.43	7.70	2.57	3.71	0.29	0.86	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	3.03	3.86	5.52	10.20	8.82	5.52	0.83	2.21	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	6.39	2.74	2.74	4.34	2.28	3.65	0.00	1.60	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	2.58	0.59	1.98	6.93	2.18	0.59	0.59	1.19	1.39
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	5.82	1.85	5.82	10.31	8.19	8.99	0.79	2.11	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	5.22	2.94	3.91	6.20	2.94	1.96	0.00	0.98	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	3.98	2.21	0.88	12.82	3.54	1.33	1.33	0.44	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	2.54	1.70	1.27	4.24	1.27	0.71	0.42	0.14	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	6.03	2.59	1.97	3.69	1.97	1.23	0.49	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	2.69	0.81	0.54	2.69	1.34	1.07	0.00	0.81	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	3.35	0.87	1.61	3.10	1.24	0.87	0.00	0.74	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	1.66	0.83	0.97	2.49	0.97	0.55	0.28	0.00	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	2.64	1.02	1.22	2.44	0.41	0.61	0.61	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	4.34	0.91	2.74	1.37	0.91	0.68	0.00	0.91	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	2.49	0.75	1.99	3.24	1.00	0.37	0.25	0.62	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	1.31	0.87	0.87	4.37	1.75	0.66	0.22	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	6.80	1.77	1.48	1.48	2.07	0.89	0.00	0.59	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	3.34	1.75	3.18	3.02	1.11	1.43	0.32	0.79	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	5.36	0.67	0.89	2.68	0.67	0.89	0.22	0.45	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	5.04	1.81	1.81	1.81	1.81	0.60	0.00	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	4.41	2.04	3.39	2.04	1.53	0.68	0.51	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	15.25	3.28	2.57	3.46	2.39	1.51	0.44	1.15	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	12.07	1.98	2.91	1.66	1.66	1.14	0.31	0.83	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	14.17	3.07	3.76	1.20	1.02	1.02	0.51	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	6.09	1.88	2.55	2.32	1.77	0.55	0.44	0.89	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	13.39	2.25	2.08	2.41	1.91	1.16	0.33	1.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	13.88	2.45	2.65	3.88	2.04	0.20	0.20	0.41	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	9.70	2.68	2.06	2.48	1.24	0.62	0.00	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	5.65	2.08	2.19	2.31	1.27	0.35	0.58	0.35	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	7.67	2.33	2.33	4.50	1.17	0.33	0.17	0.67	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	6.83	1.98	1.32	1.98	1.10	0.66	0.44	0.88	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	9.35	3.81	3.20	4.18	1.84	0.86	0.25	1.35	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	6.16	0.65	1.62	3.08	1.13	0.65	0.32	1.13	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	9.94	2.25	3.21	3.21	1.28	0.64	0.32	0.96	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	2.84	1.14	2.27	2.08	1.04	0.57	0.28	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	3.80	1.27	1.27	0.95	0.47	0.47	0.00	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	8.21	2.43	0.91	1.22	0.61	0.30	0.30	0.61	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	4.91	1.36	2.09	1.67	1.36	0.42	0.10	0.84	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	7.25	1.98	1.32	2.42	0.66	0.88	0.44	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	4.49	1.68	1.68	2.24	0.56	1.12	0.00	0.56	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	2.50	1.20	1.76	1.85	0.74	0.09	0.00	0.83	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	9.89	1.60	1.34	0.80	1.07	0.53	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	5.51	0.61	2.30	2.14	0.61	0.31	0.15	0.46	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	3.89	1.68	2.33	1.81	0.52	0.26	0.26	0.78	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	9.49	2.17	2.98	1.36	0.54	0.27	0.00	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	11.43	2.58	3.32	2.77	0.74	0.00	0.18	1.47	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	18.42	1.97	3.29	3.95	1.10	0.44	0.00	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	20.83	4.96	2.98	3.97	0.99	0.99	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	16.09	2.90	3.43	2.64	0.92	0.79	0.13	0.66	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	12.71	2.02	2.62	2.02	0.61	0.40	0.20	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	54.64	7.62	5.08	1.52	2.03	1.52	0.51	0.76	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	1.79	1.79	2.19	4.58	3.58	0.40	0.20	0.40	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	1.08	1.08	1.23	4.31	1.08	2.31	0.92	0.62	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	0.61	0.41	2.05	5.73	2.25	1.02	0.20	0.61	1.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	0.63	1.25	0.94	4.07	2.19	0.31	0.00	0.31	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	0.57	0.57	1.13	2.83	0.00	0.85	0.00	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	1.38	0.92	0.92	3.69	0.92	1.38	0.46	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	2.47	0.00	4.95	2.47	2.47	2.47	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	2.71	0.77	2.71	6.19	1.93	0.00	0.00	1.16	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	3.21	0.00	3.21	1.60	1.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	1.74	1.74	3.48	10.43	1.74	0.00	0.00	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	1.30	0.33	4.23	5.21	1.30	0.33	0.33	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	2.88	2.06	2.06	8.65	1.65	0.82	0.82	1.65	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	0.00	3.33	0.00	3.33	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	4.75	0.84	3.92	5.31	2.24	0.84	0.00	0.84	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	4.58	1.31	1.63	4.58	2.94	0.33	0.00	0.98	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	3.36	1.68	0.84	6.71	1.68	0.84	0.84	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	6.36	1.27	3.18	4.45	2.23	0.00	0.00	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	6.45	0.34	4.08	2.72	1.70	0.68	0.34	0.34	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	4.18	4.18	2.09	4.18	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	7.45	4.01	1.15	5.15	2.86	0.57	0.00	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	6.51	0.89	1.78	5.33	1.48	0.30	0.00	0.30	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	16.94	0.00	5.08	3.39	3.39	1.69	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	17.40	2.49	2.49	5.38	1.24	0.41	0.41	0.83	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	7.82	1.38	2.76	2.76	0.92	1.15	0.23	1.61	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	12.30	1.92	2.69	4.23	2.31	1.15	0.38	1.54	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	11.73	2.93	3.91	5.22	0.98	0.33	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	14.05	3.34	2.68	4.68	0.00	1.34	1.34	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	17.34	2.31	2.70	2.70	1.93	1.16	0.39	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	10.27	1.71	5.82	4.11	0.68	0.34	0.00	1.37	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	4.97	0.00	7.45	2.48	0.00	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	21.71	1.89	2.36	8.49	3.30	0.47	0.47	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	18.71	4.22	0.60	5.43	0.60	1.21	0.60	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	21.87	3.56	3.56	4.07	3.56	1.02	0.51	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	11.97	2.39	2.39	7.58	1.20	0.40	0.00	1.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	27.63	3.45	3.45	10.36	2.47	0.99	0.49	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	35.41	3.54	5.90	8.26	2.36	2.36	0.00	3.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	22.17	3.50	1.75	7.58	1.75	1.75	2.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	33.79	9.22	3.07	4.39	3.51	0.44	1.32	1.76	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	43.23	9.32	3.39	5.09	3.39	2.54	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	11.94	2.39	2.39	3.58	1.19	0.00	0.60	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	23.29	3.40	2.91	2.91	1.94	0.97	0.97	0.49	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	14.84	2.28	1.14	0.00	1.14	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	13.31	2.91	0.42	0.42	0.42	0.00	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	14.62	0.00	0.00	0.00	0.00	0.00	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	166.19	15.22	2.85	3.17	1.59	0.95	0.00	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	120.31	10.86	1.67	2.51	0.42	2.51	1.67	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	36.79	5.34	5.69	0.58	4.06	0.81	0.58	0.46	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	26.84	5.57	4.05	1.18	3.38	1.52	1.52	1.52	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	30.26	6.14	4.10	0.68	3.87	1.37	0.68	0.68	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	28.86	5.47	3.39	0.66	2.40	1.86	0.87	0.55	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	27.51	5.16	3.22	0.64	3.01	1.07	0.64	0.43	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	21.10	2.58	4.31	0.43	1.72	0.86	0.86	0.65	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	21.30	3.49	3.86	0.62	1.87	0.75	0.62	0.12	0.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	24.02	4.12	2.74	0.86	1.89	0.51	1.20	0.00	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	19.54	4.16	1.28	0.32	1.28	1.60	0.00	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	25.74	2.24	2.24	2.24	0.00	0.00	1.12	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	20.34	2.16	0.43	1.73	0.00	0.43	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	288.17	10.58	2.64	0.00	0.00	0.00	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	18.34	2.47	0.00	1.06	0.00	1.76	0.71	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.99	0.73	0.00	0.00	0.00	0.73	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	46.16	5.25	1.57	1.22	0.87	1.22	0.17	0.52	0.17
Hepatocyte, donor1	11523-119I2	33.90	3.63	2.42	0.00	0.00	2.42	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	12.93	2.15	0.00	1.08	1.08	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	53.38	6.75	3.07	0.61	1.23	1.23	1.23	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	9.79	1.31	1.31	6.53	1.31	0.65	0.00	1.96	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	3.50	0.70	1.40	1.92	1.05	0.00	0.00	0.35	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	36.09	7.82	1.65	1.78	0.82	1.78	0.82	0.82	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	6.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	5.54	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	0.00	2.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	6.50	1.62	0.00	1.62	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	3.33	0.00	0.00	1.11	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	1.89	1.26	0.00	0.63	0.00	0.00	0.00	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	1.55	0.00	0.00	1.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	1.29	1.29	0.00	0.65	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	1.61	0.00	1.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	1.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	1.68	0.00	0.00	0.00	0.00	0.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.80	2.41	0.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1.42	0.47	0.00	0.00	0.00	0.00	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	1.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	1.08	0.00	0.00	0.00	0.00	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	1.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	3.83	0.64	0.64	1.28	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	0.00	0.00	1.82	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	2.14	0.71	0.00	0.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	0.00	0.00	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	1.85	0.62	0.62	0.62	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	1.76	0.00	0.00	1.76	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.00	0.70	0.00	0.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	2.21	0.00	0.00	0.00	0.00	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	3.49	0.87	0.00	0.87	0.00	0.00	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	0.00	2.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	0.00	0.00	1.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	11.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.92	0.00	0.92	0.92	0.00	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	22.52	2.28	0.90	2.45	0.49	0.24	0.33	0.90	0.57
Keratinocyte - epidermal, donor2	11349-117G8	1.76	0.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	2.84	0.57	0.66	0.85	0.00	0.09	0.00	0.38	0.19
Keratinocyte - oral, donor1	11251-116E9	11.12	2.95	1.36	2.04	0.91	1.25	0.11	0.79	0.11
Keratocytes, donor1	11527-119I6	16.50	0.69	1.03	2.41	0.69	0.69	0.00	0.69	0.00
Keratocytes, donor2	11607-120I5	4.69	3.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	43.47	4.94	2.17	2.77	0.20	1.78	1.58	0.59	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	2.20	0.00	0.00	2.20	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	24.81	5.39	0.00	2.16	0.00	1.08	2.16	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	7.84	2.77	3.00	2.42	1.96	2.77	0.69	0.58	0.00
Lens Epithelial Cells, donor3	11690-122I7	165.90	24.32	2.52	4.24	2.02	4.54	2.83	1.31	0.81
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	88.58	9.60	2.61	1.19	1.30	1.66	0.59	0.47	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	22.88	2.51	0.84	1.95	0.28	0.00	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	119.16	12.44	3.94	2.36	1.26	0.63	0.79	1.10	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	55.92	6.45	2.69	0.00	1.61	1.08	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	17.02	1.89	0.63	1.26	0.00	0.63	0.00	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	32.45	2.37	2.37	1.40	0.54	0.43	0.11	0.32	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	54.58	4.10	4.92	1.64	0.41	0.82	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	6.83	0.76	0.25	0.25	0.00	0.25	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	34.62	4.79	0.99	1.13	0.28	0.28	0.42	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	68.82	4.35	2.77	1.19	0.79	0.40	1.98	0.79	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	35.29	1.94	2.33	1.55	1.16	0.78	0.39	0.78	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	11.66	2.04	0.37	0.19	0.19	0.00	0.19	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	48.43	4.88	2.09	1.39	0.00	1.05	0.35	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	27.91	3.58	1.43	1.67	0.72	0.00	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	26.51	2.88	0.96	2.06	0.55	0.55	0.14	0.41	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	56.66	3.39	2.16	2.16	0.92	0.92	0.92	1.23	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	10.60	0.62	0.00	0.31	0.00	0.00	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	29.10	3.48	1.65	2.20	0.37	0.37	0.55	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	54.30	3.95	1.32	1.32	0.33	0.33	0.00	1.32	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.03	2.05	1.17	2.34	0.00	0.29	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	18.67	1.99	0.25	1.00	0.25	0.50	0.00	0.00	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	78.56	7.76	4.36	1.45	0.48	1.45	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	38.51	3.77	2.15	1.62	0.27	0.54	0.81	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	57.98	6.36	1.51	1.21	0.45	0.15	0.45	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	53.40	4.67	0.52	0.52	0.00	0.52	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	45.86	3.56	1.88	3.14	0.21	0.42	0.42	0.63	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	37.74	3.46	1.20	1.50	0.30	0.30	0.30	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	55.03	5.50	6.19	0.00	0.00	0.00	0.69	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	31.04	3.57	1.88	1.69	0.00	0.75	0.38	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	20.25	2.76	0.95	1.48	0.53	0.11	0.32	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	50.40	7.75	2.91	0.97	0.97	0.48	0.97	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	21.17	2.65	0.99	1.32	0.66	0.33	0.00	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	19.45	1.86	1.49	0.99	0.62	0.12	0.00	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	102.92	10.37	7.03	3.33	2.22	0.37	0.74	1.48	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	33.85	2.96	1.48	2.96	0.49	0.49	0.25	0.49	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	15.67	2.06	0.55	1.10	0.27	0.27	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	63.04	7.08	4.50	2.57	1.61	1.29	0.00	0.64	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	50.21	4.87	2.74	3.35	0.91	1.22	0.30	1.52	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	62.84	6.30	2.94	2.24	1.12	0.84	0.56	1.26	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	61.51	6.76	2.13	2.13	1.07	1.07	0.71	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	10.67	0.97	0.48	0.48	0.00	1.45	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	13.23	2.33	0.47	0.93	0.00	0.16	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	39.03	4.66	1.79	1.07	1.43	0.36	0.72	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	20.58	1.96	0.98	2.29	0.33	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	19.78	0.94	0.00	0.71	0.00	0.00	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	82.91	10.52	2.48	1.61	0.74	1.11	1.24	0.12	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.73	1.28	0.51	1.02	0.51	0.00	0.00	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	25.36	2.39	2.09	1.19	0.00	0.90	0.30	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	0.00	0.00	2.27	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	0.77	0.00	0.00	0.77	1.53	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	0.00	0.00	0.74	1.48	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	0.42	0.00	0.42	2.12	0.42	0.00	0.00	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	0.00	0.00	0.00	0.70	0.00	0.00	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	0.00	0.00	0.00	0.00	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	0.00	0.00	0.00	1.03	0.00	0.00	0.00	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	3.57	0.00	0.00	2.38	0.00	0.00	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	1.13	0.23	0.23	0.90	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	1.16	0.29	0.29	0.87	0.29	0.00	0.00	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	2.25	0.00	0.00	0.45	0.00	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	1.35	0.27	0.27	1.08	0.27	0.00	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	0.51	1.03	0.00	1.03	0.00	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	0.71	0.71	0.71	0.71	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	0.67	0.00	0.67	0.67	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	1.53	0.51	0.00	1.02	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	1.33	0.00	0.00	0.53	0.27	0.00	0.00	0.80	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	0.94	0.00	0.57	0.57	0.19	0.00	0.00	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	1.84	0.00	0.61	1.23	0.61	0.00	0.00	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	1.63	0.00	0.82	2.45	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	1.04	0.00	0.00	0.42	0.42	0.00	0.00	0.00	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	1.96	0.00	0.28	1.12	0.28	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	1.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	0.58	0.29	0.00	0.87	0.29	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	1.79	0.30	0.30	0.00	0.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	1.11	0.55	0.00	1.66	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	2.12	0.00	0.00	0.00	0.35	0.00	0.00	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	0.74	0.00	0.74	0.74	0.37	0.00	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	0.00	0.00	0.00	1.15	1.15	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	2.30	0.38	0.00	1.54	0.38	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	0.57	0.00	0.57	1.13	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	0.82	0.00	0.00	0.82	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	0.90	0.00	0.00	1.36	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	1.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	1.49	0.00	0.00	1.49	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	1.11	0.00	0.00	0.74	0.00	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	1.72	0.43	0.00	0.86	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	1.71	0.86	0.00	0.86	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	2.00	0.33	0.00	1.00	0.33	0.00	0.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	1.81	0.00	0.00	0.60	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	1.03	0.00	0.34	0.00	0.69	0.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	0.54	0.00	0.00	1.07	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	0.00	0.00	0.00	2.02	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	1.11	0.37	0.37	1.11	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	3.49	0.00	0.00	3.49	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	3.17	0.00	0.00	2.12	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	0.80	0.00	0.40	0.40	0.80	0.00	0.00	1.20	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	3.63	0.00	0.73	0.73	0.00	0.00	0.00	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	3.07	0.00	0.77	0.77	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	0.99	0.49	0.00	1.48	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	0.94	0.00	0.00	0.94	0.00	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	1.01	0.00	0.50	1.01	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	3.60	0.90	0.00	0.90	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	0.89	0.00	0.89	0.89	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	1.56	0.00	0.39	0.78	0.39	0.00	0.00	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	0.66	0.00	0.00	0.00	1.32	0.00	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	0.52	0.00	0.00	0.52	0.00	0.00	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	2.19	0.00	0.88	0.44	0.00	0.00	0.44	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	1.68	0.00	0.00	0.56	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	0.44	0.44	0.88	1.77	0.44	0.00	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	3.09	0.00	0.77	0.77	0.39	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	1.52	0.51	1.52	0.51	0.00	0.00	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	0.96	0.00	0.00	1.92	0.00	0.00	0.00	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	1.59	0.40	0.40	1.19	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	0.00	0.61	1.22	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	0.69	0.00	0.69	0.00	0.00	0.00	0.00	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	2.28	0.00	0.38	1.14	0.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	1.03	0.00	0.52	1.03	0.00	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	0.63	0.32	0.00	1.90	0.00	0.00	0.00	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	0.53	0.00	0.53	1.07	0.00	0.00	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	1.15	0.57	0.00	0.57	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	0.00	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	0.71	0.00	0.00	0.71	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	0.83	0.42	0.00	1.25	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	0.78	0.00	0.00	1.57	0.78	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	0.00	0.00	0.00	0.42	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	0.46	0.00	0.93	0.00	0.46	0.00	0.00	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	0.67	0.00	0.00	2.01	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	0.53	0.00	0.00	0.53	0.00	0.00	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	0.81	0.00	0.00	2.02	0.00	0.40	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	0.92	0.00	0.92	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	0.00	0.00	1.78	0.89	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	2.28	0.00	0.00	0.57	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	0.00	0.00	0.00	1.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	0.00	0.55	0.00	0.00	0.55	0.00	0.00	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	0.45	0.00	0.89	1.34	0.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	0.26	0.00	0.52	0.00	0.00	0.00	0.26	0.52	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	0.00	0.00	0.66	0.66	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	11.17	3.42	1.14	1.14	0.46	0.68	1.82	0.68	0.00
Macrophage - monocyte derived, donor2	11313-117C8	11.38	1.65	0.92	0.37	0.37	0.00	0.37	0.73	0.18
Macrophage - monocyte derived, donor3	11389-118C3	3.67	1.97	0.52	0.52	0.26	0.00	0.00	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	64.25	6.37	4.78	1.59	1.06	0.00	0.53	1.06	1.06
Mallassez-derived cells, donor2	11929-125I3	364.60	29.31	9.98	6.65	2.69	2.85	2.06	3.33	0.63
Mallassez-derived cells, donor3	11930-125I4	58.51	10.01	4.59	2.36	2.22	1.25	0.97	0.69	0.42
Mammary Epithelial Cell, donor1	11273-116H4	12.56	2.69	1.89	2.19	0.80	0.40	0.10	1.30	0.20
Mammary Epithelial Cell, donor2	11350-117G9	11.29	0.87	0.87	0.87	0.29	0.00	0.00	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	0.50	0.00	0.25	0.25	0.75	0.25	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	236.60	37.96	14.24	2.71	4.07	23.05	3.39	2.03	1.36
Mast cell, donor1	11563-120D6	14.71	3.57	1.73	1.30	0.43	1.19	0.43	0.54	0.00
Mast cell, donor2	11565-120D8	211.89	27.34	7.13	0.89	1.49	4.46	2.38	1.19	0.30
Mast cell, donor3	11566-120D9	170.87	27.47	2.93	2.93	1.35	6.75	4.50	0.45	0.23
Mast cell, donor4	11567-120E1	267.35	30.49	6.91	1.42	2.30	2.66	2.13	0.18	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	34.38	4.32	3.33	2.55	1.89	0.67	1.11	0.67	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	50.20	4.67	2.92	4.67	0.58	0.00	2.33	1.75	0.00
Mast cell, expanded, donor5	11939-126A4	9.29	1.72	2.87	1.03	1.03	0.46	0.92	0.92	0.00
Mast cell, expanded, donor8	11941-126A6	37.32	1.67	1.84	1.51	1.00	0.50	1.00	0.67	0.00
Melanocyte - dark, donor1	11502-119F8	295.81	30.55	13.13	3.58	5.67	4.88	3.88	1.69	0.50
Melanocyte - dark, donor2	11582-120F7	21.46	2.08	0.69	0.69	0.69	0.35	0.00	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	5.07	1.67	1.52	1.16	0.87	0.29	0.29	0.65	0.14
Melanocyte - light, donor1	11274-116H5	2.59	0.94	0.71	1.65	0.24	0.24	0.00	0.47	0.00
Melanocyte - light, donor2	11351-117H1	0.00	0.00	0.00	1.36	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	1.73	1.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	7.18	2.19	0.94	2.19	0.83	0.00	0.42	0.62	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	2.96	1.34	2.42	1.61	0.81	0.00	0.27	0.00	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	5.62	1.61	3.21	0.80	0.54	0.54	0.00	0.80	0.27
Meningeal Cells, donor1	11493-119E8	39.45	8.44	2.85	1.86	0.12	0.62	1.12	0.37	0.25
Meningeal Cells, donor2	11573-120E7	12.76	3.08	1.76	4.84	0.44	0.00	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	123.07	16.38	5.13	2.04	2.45	2.61	1.55	0.82	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	38.21	4.85	0.86	2.57	1.14	1.14	0.00	0.86	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	183.75	16.30	2.42	1.91	1.71	1.61	0.91	0.70	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	1.31	0.00	1.31	0.00	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	102.62	12.20	0.72	1.44	2.15	2.15	2.15	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	29.65	3.81	1.27	2.75	0.85	0.85	0.64	0.64	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	13.07	3.02	1.01	1.51	0.50	1.51	1.01	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	11.21	1.54	0.88	1.54	0.66	0.22	0.66	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	7.31	0.73	0.00	1.46	0.73	0.73	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7.16	0.82	0.20	2.25	0.61	0.00	0.20	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	89.06	15.51	3.05	5.12	1.52	0.97	0.97	0.55	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	14.50	1.49	0.74	0.74	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	190.91	13.29	3.29	3.95	2.76	2.50	1.05	0.13	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	15.73	2.67	0.89	1.78	0.30	0.30	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	0.00	0.00	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	17.93	4.48	0.00	1.28	0.00	0.64	0.00	0.64	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	202.74	19.49	5.32	2.13	2.13	2.48	0.71	2.84	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	124.15	8.44	3.75	3.44	2.19	3.44	0.94	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	31.93	3.63	0.73	2.90	0.00	0.73	0.00	0.73	0.73
Mesothelial Cells, donor1	11247-116E5	114.56	11.14	4.77	2.92	2.12	0.80	0.27	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	155.14	10.51	4.00	1.50	1.50	2.00	2.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	38.59	4.62	0.65	1.73	1.08	0.29	0.36	0.58	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	17.55	2.70	1.35	1.35	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	10.34	3.94	0.99	0.99	0.99	0.25	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	2.94	1.18	0.29	0.59	0.59	0.00	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	11.47	1.55	1.55	1.24	0.62	0.31	0.31	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	4.77	1.04	0.21	0.83	0.41	0.00	0.21	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	32.28	3.25	1.25	1.00	1.50	1.00	0.75	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.98	2.33	0.93	0.00	0.93	0.00	0.00	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	45.52	5.49	1.42	0.41	0.81	0.41	0.61	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	7.92	0.79	0.79	0.40	0.40	0.00	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	62.83	7.08	2.65	0.00	0.00	0.88	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	30.02	1.90	1.52	0.38	0.38	0.00	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	0.00	1.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	105.69	8.91	0.85	0.21	0.00	0.00	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	4.60	0.00	0.00	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	68.55	5.66	2.09	0.60	0.30	0.30	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	1.68	0.00	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	102.37	10.04	1.51	0.75	0.25	0.00	0.50	0.75	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	19.49	3.09	0.48	0.24	1.19	0.00	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	28.75	4.98	0.55	0.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	108.68	10.59	3.45	0.23	0.46	0.69	0.69	0.46	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	17.88	2.52	0.42	0.00	1.05	0.21	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	25.48	5.30	1.02	0.20	0.41	0.41	0.20	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	51.06	9.01	1.07	0.00	0.21	0.43	0.86	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	10.67	1.33	0.89	0.00	0.22	0.22	0.00	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	29.35	3.50	1.75	0.00	0.66	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	7.10	0.51	0.00	0.00	1.01	0.00	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	37.51	7.07	1.36	0.27	0.27	0.00	0.82	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.29	1.18	0.88	0.29	1.47	0.00	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	2.18	1.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	8.65	1.44	1.44	0.00	0.96	0.48	0.48	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	11.61	1.20	0.40	1.20	0.80	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	10.97	2.74	0.00	0.00	0.00	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	7.01	1.50	0.50	0.50	0.50	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	8.76	2.19	2.19	0.00	0.00	0.44	1.75	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	6.62	0.00	0.00	1.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.39	1.98	1.74	0.25	0.00	0.00	1.24	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.13	1.39	2.09	0.00	0.70	0.00	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	7.18	1.71	1.37	0.00	1.03	0.00	0.68	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	9.19	1.31	1.31	0.44	1.31	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	4.97	1.78	0.00	0.00	0.00	0.00	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	4.77	2.81	2.52	0.56	1.12	0.28	0.56	0.84	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	5.40	1.25	0.83	0.83	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.58	0.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	3.32	1.21	2.11	0.30	0.60	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	15.03	3.34	2.50	0.00	0.83	0.42	0.83	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	11.08	2.77	0.92	0.92	1.85	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	18.78	5.69	1.71	1.14	0.57	0.57	1.14	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	4.97	3.04	0.83	0.55	0.41	0.69	0.55	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	7.52	1.30	0.26	0.00	0.26	0.52	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.44	3.86	2.57	0.43	0.86	0.43	0.43	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	1.27	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	7.74	1.60	1.60	0.27	1.07	0.53	0.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	13.17	5.69	2.10	0.30	0.60	0.60	0.90	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	3.11	1.70	0.57	0.71	0.28	0.14	0.28	0.14	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	8.28	2.23	1.59	0.32	0.64	0.00	0.32	0.32	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	23.22	5.97	2.43	0.88	0.22	0.44	0.00	0.66	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	3.41	1.90	0.38	0.38	0.00	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	16.76	3.13	1.42	0.85	1.70	1.14	0.28	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	24.09	5.16	2.46	0.74	0.25	0.00	0.49	0.74	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	5.21	0.65	0.65	0.00	0.00	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	15.00	3.53	1.47	0.88	0.59	0.59	1.18	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	13.84	4.32	0.86	0.58	0.86	0.58	0.58	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	18.13	5.77	0.82	0.00	0.00	2.47	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	5.66	1.49	1.49	1.79	0.60	0.00	0.60	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	7.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	1.78	5.35	0.00	0.00	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	3.61	0.66	0.66	0.00	0.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	6.31	3.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	10.87	2.57	1.19	0.79	0.79	0.59	1.78	1.19	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	1.86	0.93	1.86	0.00	1.86	0.00	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	1.88	2.25	2.63	0.00	0.75	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	3.73	2.13	0.53	0.27	0.27	0.27	0.53	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	11.42	1.92	0.79	0.45	0.11	0.23	0.57	0.45	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	4.42	0.74	0.00	0.00	0.00	0.00	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	4.40	1.83	0.00	0.37	0.00	0.37	0.00	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	6.22	3.11	1.56	0.00	0.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	88.72	4.81	0.53	0.53	1.60	0.00	0.53	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	6.06	1.01	1.01	1.01	1.01	0.00	0.00	1.01	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.43	0.00	1.69	0.84	0.84	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	856.66	21.79	2.72	4.09	0.00	0.00	4.09	0.00	2.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	320.44	13.99	0.64	0.00	0.00	1.27	1.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	462.42	18.63	0.81	0.00	0.00	0.00	0.00	0.81	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	385.16	15.10	3.02	3.02	0.00	0.00	4.53	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	1261.95	17.13	0.00	5.71	0.00	0.00	5.71	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3755.08	114.19	6.52	9.79	3.26	0.00	9.79	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	883.96	4.75	0.00	4.75	9.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	288.63	25.10	0.00	12.55	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	158.78	12.71	1.94	3.45	1.94	1.72	1.51	1.08	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	29.27	6.27	3.14	1.57	0.00	0.52	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	42.72	4.00	3.34	2.00	0.67	0.67	0.00	1.33	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	39.65	7.10	0.83	0.42	0.00	0.00	0.42	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	135.38	24.53	4.75	8.75	3.04	3.42	0.38	2.09	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	403.75	63.83	6.38	4.79	3.19	3.19	0.00	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	32.64	4.76	0.68	1.36	0.68	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	485.14	53.29	18.38	14.70	9.19	9.19	5.51	3.68	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	29.30	3.77	0.42	2.51	0.42	0.42	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	85.30	15.11	0.46	2.09	0.46	1.16	0.93	0.46	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	23.51	2.43	0.54	1.08	0.27	0.54	0.27	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	53.19	7.78	1.68	3.99	0.42	0.21	1.26	0.63	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1603.40	189.29	33.40	22.27	33.40	22.27	55.67	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	44.18	3.47	0.99	0.50	0.00	0.00	0.99	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	63.07	11.10	1.62	5.95	2.71	0.54	0.27	2.17	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	85.69	9.75	0.45	2.04	0.68	0.68	0.91	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	20.41	1.80	0.33	2.61	0.65	0.65	0.65	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	67.62	11.48	2.92	2.73	0.91	0.73	1.28	1.09	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	49.33	4.24	1.59	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	22.21	2.40	0.60	2.40	0.00	0.00	1.20	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	148.34	22.32	4.92	14.77	2.30	3.61	2.95	1.31	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	46.51	6.83	0.98	1.63	0.33	0.98	0.49	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	103.18	10.94	2.47	4.23	1.59	2.82	1.06	0.88	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	42.90	4.92	0.70	0.00	0.70	0.70	0.00	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	21.61	4.14	0.00	4.14	0.00	0.00	0.00	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	42.74	5.78	1.61	3.86	0.64	0.00	0.32	1.29	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	273.15	39.66	4.14	7.24	2.41	6.21	4.14	1.72	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	379.27	108.72	7.59	32.87	5.06	22.76	15.17	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	96.24	11.58	3.12	4.23	0.45	0.89	1.11	0.67	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	40.22	4.23	2.12	2.96	0.85	0.00	0.42	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	52.22	7.36	1.90	2.85	1.19	0.47	1.42	0.71	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	40.35	7.30	2.58	2.15	0.86	0.00	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1724.30	325.00	27.08	27.08	27.08	36.11	9.03	9.03	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	24.66	4.33	0.67	4.33	1.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	108.21	16.68	0.90	2.71	0.90	0.45	3.16	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	76.98	8.33	0.79	0.79	0.40	0.40	0.00	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	26.00	2.79	0.93	0.93	0.00	0.00	1.86	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	71.13	11.73	1.89	4.92	1.14	1.51	0.76	1.14	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	50.84	4.24	0.65	2.28	0.33	0.00	0.00	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.97	2.18	1.31	1.74	0.44	0.44	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	222.07	23.97	3.17	3.17	1.81	1.36	2.26	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	67.03	9.70	1.76	0.88	0.88	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	34.57	2.66	0.00	1.33	0.66	0.66	1.33	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	34.23	3.97	1.98	3.47	0.50	0.50	0.00	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	38.28	5.36	1.15	0.00	0.00	0.38	1.15	0.38	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	23.89	5.75	1.81	10.59	0.91	0.30	0.91	0.60	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	126.20	14.81	3.09	4.86	0.44	0.66	1.99	0.88	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	62.34	8.81	3.39	1.36	1.36	0.00	0.68	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	618.25	112.41	10.22	25.55	20.44	20.44	5.11	15.33	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	25.00	2.44	3.05	1.83	0.61	0.00	0.61	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	27.38	6.29	0.31	2.20	0.94	0.31	1.89	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.36	3.03	0.91	2.42	0.30	0.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	82.28	11.08	2.37	3.16	0.00	0.00	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	299.28	22.67	5.67	7.94	3.40	2.27	5.67	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	890.19	65.75	35.41	30.35	15.17	5.06	5.06	5.06	0.00
Myoblast, donor1	11241-116D8	529.96	24.47	5.34	4.47	1.49	2.24	3.73	1.37	1.74
Myoblast, donor2	11322-117D8	82.66	7.48	1.53	6.52	1.15	1.34	0.77	0.58	0.38
Myoblast, donor3	11398-118D3	770.69	32.96	3.03	4.71	2.19	4.88	4.54	1.68	1.85
NK T cell leukemia cell line:KHYG-1	10777-110G3	6.57	1.61	0.29	2.63	0.44	0.15	0.15	0.15	0.44
Natural Killer Cells, donor1	11230-116C6	38.44	10.76	1.85	3.69	0.31	0.31	0.31	0.62	1.85
Natural Killer Cells, donor2	11311-117C6	18.39	5.73	0.90	3.92	0.00	0.60	0.00	0.60	1.81
Natural Killer Cells, donor3	11387-118C1	16.20	9.75	0.92	4.23	0.18	0.37	0.92	0.00	2.21
Neural stem cells, donor1	11275-116H6	5.81	2.90	2.54	1.81	1.81	1.09	0.36	2.18	0.00
Neural stem cells, donor2	11352-117H2	0.00	3.85	3.85	5.78	1.93	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	7.97	1.14	2.28	2.28	4.55	1.14	0.00	1.14	0.00
Neurons, donor2	11574-120E8	5.28	0.88	2.64	1.98	2.20	0.44	0.00	0.44	0.44
Neurons, donor3	11655-122E8	5.76	0.82	4.11	4.11	2.47	0.82	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	0.93	0.00	2.78	0.93	0.93	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	5.80	2.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	4.89	2.44	1.83	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	95.46	12.82	2.14	4.51	1.42	3.44	0.83	1.31	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	21.49	1.95	1.30	2.60	0.98	0.65	0.33	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	32.49	7.42	0.80	3.81	0.40	1.00	0.40	0.80	0.20
Olfactory epithelial cells, donor1	11933-125I7	49.97	7.98	1.79	2.62	0.55	1.10	0.69	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	73.39	10.71	2.46	0.87	0.72	1.16	1.01	1.01	0.29
Olfactory epithelial cells, donor3	11935-125I9	47.56	6.70	2.27	1.14	1.36	0.68	1.02	0.57	0.23
Olfactory epithelial cells, donor4	11936-126A1	104.31	11.59	3.02	1.95	1.36	1.36	0.78	0.78	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	19.86	3.61	3.01	0.60	1.81	0.60	0.00	1.81	0.60
Osteoblast - differentiated, donor1	11276-116H7	87.42	7.23	1.06	1.06	0.43	0.85	1.28	0.43	0.21
Osteoblast - differentiated, donor2	11353-117H3	3.43	0.00	1.14	0.00	0.00	0.00	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	12.41	1.86	3.72	1.86	0.62	0.62	0.62	0.62	0.00
Osteoblast, donor1	11277-116H8	2.35	0.00	0.20	0.39	0.20	0.20	0.00	0.20	0.00
Osteoblast, donor2	11354-117H4	68.83	10.53	2.11	2.81	2.11	1.40	2.81	0.00	0.00
Osteoblast, donor3	11426-118G4	22.04	3.73	1.60	1.96	0.89	0.89	0.36	0.53	0.00
Pancreatic stromal cells, donor1	11249-116E7	43.97	7.08	3.62	3.37	1.85	1.68	0.84	1.01	0.00
Pericytes, donor1	11491-119E6	10.90	1.89	0.11	3.00	0.00	0.11	0.22	0.11	0.22
Pericytes, donor2	11571-120E5	8.60	2.04	0.45	3.17	0.23	0.00	0.23	0.23	0.00
Pericytes, donor3	11652-122E5	71.61	7.73	1.42	1.83	0.20	0.41	0.20	0.20	0.41
Perineurial Cells, donor1	11499-119F5	225.25	21.81	4.41	4.41	1.70	5.20	1.58	0.79	0.45
Perineurial Cells, donor2	11579-120F4	38.83	5.61	2.30	1.38	0.92	1.01	0.55	0.64	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	22.95	5.74	1.59	2.23	0.32	0.32	0.64	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	12.73	6.86	0.73	1.22	0.49	0.00	0.49	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	3.62	1.16	0.13	0.52	0.13	0.13	0.13	0.13	0.39
Placental Epithelial Cells, donor1	11278-116H9	16.02	1.91	2.15	0.72	1.43	0.48	0.00	0.48	0.24
Placental Epithelial Cells, donor2	11355-117H5	39.92	3.33	2.22	0.00	0.00	0.00	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	3.14	0.98	1.37	0.20	0.20	0.20	0.20	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	37.34	5.06	1.90	0.95	0.95	0.95	0.32	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	200.72	12.76	3.75	3.56	3.00	1.50	3.00	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	157.68	22.58	1.96	2.74	1.83	1.70	1.83	0.65	0.13
Preadipocyte - breast, donor2	11328-117E5	44.13	6.30	2.70	2.03	0.90	0.90	0.68	0.68	0.00
Preadipocyte - omental, donor1	11468-119C1	186.69	16.62	5.43	3.52	3.20	1.70	3.73	1.81	0.64
Preadipocyte - omental, donor2	11329-117E6	87.29	12.66	2.62	4.36	2.18	2.18	3.49	1.75	0.44
Preadipocyte - omental, donor3	11403-118D8	76.07	7.59	3.58	3.44	1.86	1.15	1.29	2.01	0.72
Preadipocyte - perirenal, donor1	11469-119C2	23.62	10.83	0.00	2.95	0.98	0.00	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	35.01	0.92	0.92	1.54	0.31	0.31	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	89.07	12.22	4.43	3.01	2.30	0.89	1.24	2.12	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	84.80	13.62	2.55	2.04	0.68	0.51	0.85	1.02	0.17
Preadipocyte - visceral, donor1	11280-116I2	114.66	13.69	3.63	8.38	2.42	1.77	1.21	2.05	1.02
Preadipocyte - visceral, donor2	11357-117H7	47.86	5.52	2.30	4.60	1.38	0.92	1.38	0.00	0.92
Preadipocyte - visceral, donor3	11429-118G7	61.13	10.55	1.57	2.09	0.94	0.63	0.52	0.84	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	5.58	0.60	1.21	1.21	1.36	0.30	0.00	0.60	0.15
Prostate Epithelial Cells, donor2	11331-117E8	59.85	4.33	2.71	1.22	2.17	0.81	0.68	1.08	0.41
Prostate Epithelial Cells, donor3	11404-118D9	1.59	0.80	1.96	0.98	0.80	0.80	0.06	0.24	0.06
Prostate Stromal Cells, donor1	11254-116F3	32.92	5.24	2.05	1.94	1.59	0.91	0.11	0.91	0.34
Prostate Stromal Cells, donor2	11332-117E9	29.58	3.94	2.33	3.94	1.08	0.54	0.36	0.72	0.36
Prostate Stromal Cells, donor3	11405-118E1	31.91	4.28	1.36	1.46	1.15	0.52	0.42	0.52	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	1.46	0.36	0.00	0.00	0.00	0.36	0.00	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	2.77	0.83	1.39	1.18	0.69	0.83	0.28	0.42	0.00
Renal Epithelial Cells, donor1	11517-119H5	0.00	0.51	0.00	0.51	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	1.42	0.00	1.42	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	6.03	1.59	2.86	1.59	1.48	0.85	0.00	0.74	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	3.40	1.36	0.00	0.68	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	10.78	2.70	0.40	1.35	0.00	0.13	0.13	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	25.53	4.88	1.33	1.33	0.89	1.11	1.11	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	2.00	0.67	0.67	3.33	0.00	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	6.16	1.76	0.22	1.32	0.22	0.22	0.22	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	0.63	0.63	0.00	1.25	0.00	0.00	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	0.28	0.28	0.00	1.11	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	1.34	1.61	0.00	0.54	1.88	0.00	0.54	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	0.42	0.42	0.00	0.00	0.42	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	0.77	0.39	0.39	0.77	0.00	0.39	0.00	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	3.11	0.26	1.56	1.04	0.52	1.04	0.00	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.54	1.14	0.28	2.84	0.57	0.00	0.28	1.42	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	0.00	0.00	0.00	2.06	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	22.58	5.02	0.75	1.76	0.50	1.00	0.50	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	377.39	29.80	10.42	1.74	8.82	4.81	6.41	0.67	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	63.43	7.15	13.40	21.44	4.47	0.00	1.79	0.00	4.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	128.79	15.96	44.03	45.13	11.01	3.85	2.20	12.11	4.95
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	108.47	15.08	23.78	22.62	8.70	1.74	1.74	6.38	4.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	82.44	28.74	13.13	20.67	4.81	1.30	1.95	2.21	2.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	38.63	13.51	10.03	10.33	4.47	0.99	0.70	4.47	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	78.86	16.28	15.50	18.18	4.91	3.12	1.00	6.02	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	78.77	21.58	18.61	20.34	5.21	2.36	2.11	5.33	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	38.46	12.59	9.09	11.77	3.15	1.40	0.93	2.91	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	75.81	19.88	14.56	22.19	6.47	1.62	1.62	6.93	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	42.72	13.96	8.49	19.17	3.29	0.68	0.68	2.46	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	60.36	14.82	10.59	12.56	3.63	2.57	1.51	4.69	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	64.69	14.69	12.72	15.23	5.73	1.97	1.08	3.76	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	35.29	12.34	8.46	15.64	2.73	0.43	0.43	2.01	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	42.28	11.48	10.52	9.44	5.15	1.18	0.75	3.76	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	53.55	17.26	11.06	16.60	4.65	1.55	0.66	4.65	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	33.07	14.53	8.41	16.06	3.06	0.57	0.96	2.49	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	44.35	11.83	10.25	14.07	2.89	1.30	0.56	3.54	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	106.73	18.98	14.66	20.11	6.95	1.32	1.88	6.39	3.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	41.27	15.26	6.64	16.59	2.39	0.80	0.93	2.79	1.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	33.87	13.14	9.93	11.49	3.41	1.46	0.58	4.58	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	47.93	13.37	13.56	17.00	4.58	1.53	1.15	3.25	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	34.49	11.96	8.12	13.35	3.10	0.75	1.28	1.17	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	46.81	13.45	6.45	7.85	1.96	0.28	1.12	3.92	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	41.53	9.23	9.74	15.89	3.42	1.03	0.34	4.27	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	30.27	11.49	6.93	13.13	4.01	0.91	0.91	1.82	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	28.57	8.58	6.01	7.97	2.70	0.74	0.00	4.41	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	29.28	9.00	9.81	11.01	4.03	0.81	0.81	4.57	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	48.83	15.10	12.74	16.28	4.48	0.94	0.94	1.89	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	26.19	13.10	8.93	8.53	3.37	0.60	0.00	4.56	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	36.95	10.29	10.52	13.10	4.21	0.94	0.23	3.74	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	36.91	18.66	10.58	16.17	5.39	1.24	1.66	2.49	1.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	51.10	15.48	8.63	10.84	3.32	0.88	0.88	4.65	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	30.29	8.56	10.44	13.79	4.60	0.84	0.42	3.34	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	38.49	16.69	11.04	16.15	7.13	1.08	1.62	3.50	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	47.51	13.79	7.83	12.26	3.92	1.36	0.68	5.79	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	45.50	14.07	11.57	17.74	6.17	0.96	0.96	4.43	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	62.59	22.18	14.61	21.49	6.02	1.20	2.06	3.78	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	50.07	18.79	13.03	11.52	5.08	1.23	1.37	4.39	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	106.87	28.40	20.69	17.73	8.37	2.13	0.66	3.78	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	50.11	16.36	10.23	16.19	3.75	1.19	1.70	1.53	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	38.32	11.39	10.95	15.09	5.62	1.04	0.15	3.85	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	68.24	14.66	15.46	15.19	5.06	2.40	0.80	2.13	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	23.37	8.02	10.09	26.27	3.59	0.28	0.83	1.80	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	41.91	7.62	10.00	11.91	4.05	0.24	0.71	2.62	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	90.90	21.97	12.29	18.34	6.85	1.81	1.61	3.83	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	31.83	8.66	8.19	18.08	2.83	0.57	0.38	2.17	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	45.42	12.23	15.37	25.85	5.24	1.75	0.70	4.19	4.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	37.17	7.56	20.25	18.44	6.35	0.30	0.60	5.14	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	33.53	9.67	9.55	18.11	3.67	0.24	0.86	1.35	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	117.32	18.78	29.11	67.97	11.06	1.89	0.29	12.37	7.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	68.14	7.91	20.69	18.86	3.04	1.83	0.00	4.87	4.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	46.72	15.07	10.85	14.77	5.73	0.00	1.21	1.81	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	30.99	4.75	11.76	21.26	2.49	0.00	0.90	3.39	2.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	54.82	8.99	23.96	27.56	9.88	1.50	0.60	5.39	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	38.73	10.15	15.70	24.80	4.25	0.35	0.59	1.77	3.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	21.98	6.40	13.45	18.14	3.84	0.64	0.21	1.71	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	76.93	16.23	23.44	30.05	6.01	1.20	0.60	7.21	4.21
Schwann Cells, donor1	11498-119F4	4.70	1.13	0.00	1.32	0.00	0.00	0.00	0.00	0.38
Schwann Cells, donor2	11578-120F3	27.22	0.00	6.80	0.00	0.00	0.00	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	39.65	6.57	2.63	1.31	1.10	0.22	0.44	0.66	0.22
Sebocyte, donor1	11220-116B5	31.77	6.57	0.55	2.19	0.00	3.29	0.55	0.55	0.00
Sebocyte, donor2	11301-117B5	7.35	1.38	0.00	3.22	0.00	0.00	0.00	0.92	0.00
Sebocyte, donor3	11378-118B1	28.86	2.68	1.24	3.30	0.62	1.03	0.41	0.21	0.41
Sertoli Cells, donor1	11255-116F4	64.61	1.66	0.00	6.63	3.31	1.66	1.66	1.66	0.00
Sertoli Cells, donor2	11333-117F1	73.43	5.65	2.82	2.82	0.00	2.82	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	17.33	1.94	1.41	1.85	0.88	0.79	0.97	0.53	0.00
Skeletal Muscle Cells, donor2	11358-117H8	1.45	0.00	0.00	1.45	0.72	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	3.34	0.00	0.84	3.34	0.00	0.00	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	57.81	11.15	1.10	3.77	1.41	2.04	0.16	0.16	0.47
Skeletal Muscle Cells, donor5	11455-119A6	37.01	9.51	2.08	2.97	1.19	0.89	0.30	0.30	0.15
Skeletal Muscle Cells, donor6	11459-119B1	144.21	21.39	2.46	3.69	1.39	1.85	1.85	0.62	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	69.43	10.33	2.52	10.21	1.13	1.51	1.01	2.14	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	23.83	4.71	1.71	4.99	0.43	1.14	0.86	0.57	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	46.13	8.43	2.58	4.27	0.69	1.59	0.79	0.69	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	51.31	6.49	1.94	3.45	1.94	0.84	0.76	0.84	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	1.45	0.72	0.00	3.62	0.00	0.00	0.00	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	4.27	0.41	0.00	1.24	0.00	0.14	0.00	0.14	0.00
Skin - palm, donor1	10286-104F7	51.04	2.69	0.00	0.00	0.00	0.00	5.37	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.77	1.73	0.29	0.43	0.43	0.14	0.00	0.29	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	28.63	4.09	4.91	17.18	0.82	0.00	0.00	2.45	8.18
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	4.28	0.65	0.78	0.52	0.13	0.26	0.00	0.39	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	19.74	3.34	2.22	2.64	0.83	0.70	0.42	0.97	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	4.50	0.70	0.42	0.70	0.42	0.28	0.00	0.28	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	26.22	5.29	1.90	11.84	0.63	1.06	0.42	2.96	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	5.70	1.20	0.90	1.05	0.60	0.60	0.00	0.82	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	57.71	11.42	1.85	3.39	0.93	0.93	1.23	0.93	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	195.43	30.24	1.11	7.56	0.67	0.67	2.22	0.22	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	35.86	5.29	5.29	1.18	0.59	0.00	0.00	1.18	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	16.57	3.54	0.22	0.88	0.44	0.66	0.22	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	23.23	2.36	0.00	1.18	0.39	0.00	0.00	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	46.35	2.32	0.77	0.77	0.00	0.00	0.77	0.00	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	54.04	10.01	2.00	0.00	1.00	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	13.04	2.00	1.20	0.40	0.40	0.27	0.00	0.27	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	106.39	14.85	3.32	2.66	1.77	2.22	1.11	0.66	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	44.04	7.94	1.15	2.05	0.51	0.64	0.90	0.77	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	84.65	13.35	3.58	3.26	1.63	1.63	0.65	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	265.50	21.85	4.13	6.20	0.89	3.25	2.66	0.89	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	93.39	9.11	1.85	4.27	1.42	0.57	0.43	0.43	0.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	50.92	3.90	0.98	0.65	0.16	1.14	0.16	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	67.28	5.78	2.74	5.48	0.61	0.61	0.30	1.22	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	10.36	1.77	0.76	0.76	0.51	0.25	0.00	0.25	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	5.25	0.95	0.48	2.38	0.95	0.00	0.00	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	142.61	17.25	2.80	3.83	1.33	1.47	1.62	1.03	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	45.63	6.89	1.51	1.94	0.65	0.65	0.22	0.86	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	45.97	5.56	1.68	3.57	0.73	0.84	0.31	0.63	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	31.09	3.56	0.46	0.77	0.15	0.46	0.15	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	46.35	3.23	0.00	2.16	0.00	2.16	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	12.85	2.39	1.49	0.60	0.30	0.30	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	17.41	1.37	1.02	1.71	0.34	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	120.07	12.41	2.51	3.85	2.43	1.49	0.47	0.47	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	185.98	18.62	7.75	6.14	2.31	4.33	3.22	1.91	1.61
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	35.27	4.78	3.41	3.19	1.14	1.14	0.68	0.23	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	12.08	4.83	0.60	0.60	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	99.61	21.46	6.09	3.18	2.91	2.12	2.12	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	26.90	5.99	1.46	2.53	0.53	0.67	1.33	0.67	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	18.16	4.63	0.38	1.13	0.75	0.50	0.00	0.38	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	21.56	4.82	1.78	0.25	0.76	0.25	1.78	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	86.85	9.20	2.56	2.11	0.60	1.66	2.11	1.21	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	6.00	0.75	1.50	2.25	1.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	77.53	23.26	1.29	1.29	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	6.98	1.40	0.47	0.00	0.00	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	41.91	6.56	0.50	1.01	0.50	0.50	1.51	1.51	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	28.83	4.39	0.63	0.31	0.63	0.31	0.00	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	20.06	0.88	0.88	1.18	0.88	0.00	0.29	0.29	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	97.14	13.33	2.50	2.75	1.58	1.75	1.17	1.17	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	35.04	2.34	2.34	1.40	1.87	1.40	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	35.98	3.60	0.72	1.44	0.00	0.72	0.43	0.00	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	10.20	1.02	0.76	0.51	0.25	0.25	0.76	0.51	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.65	1.88	0.19	0.00	0.75	0.19	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	328.82	27.81	4.19	4.61	3.07	4.75	3.77	1.82	0.84
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	364.23	27.48	2.60	2.51	1.76	5.70	3.10	0.92	0.50
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	16.67	0.48	0.48	0.95	0.48	0.48	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	36.70	3.43	1.22	1.47	0.49	0.73	0.00	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	108.49	13.92	2.43	1.99	1.10	0.66	0.88	0.88	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	15.51	4.39	1.17	2.05	0.88	0.88	0.88	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	14.58	4.08	1.36	2.72	0.58	0.19	0.97	0.78	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	219.76	17.98	3.17	1.85	0.26	0.79	1.85	1.59	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	51.33	8.55	2.23	2.23	1.49	0.00	0.74	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	168.53	11.14	2.52	6.83	1.08	1.44	1.44	1.44	1.80
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	89.71	5.39	3.41	1.70	1.70	0.57	1.14	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	40.17	9.06	2.76	1.97	2.76	0.39	0.39	1.58	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	70.85	7.11	3.05	4.57	0.76	0.51	1.27	0.51	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	32.74	4.79	2.00	3.99	1.20	0.40	0.40	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	51.83	4.60	2.51	1.67	0.00	0.42	0.42	0.84	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	26.13	3.67	3.21	1.38	1.83	0.46	0.00	0.46	0.00
Synoviocyte, donor1	11291-117A4	706.11	44.44	7.57	2.19	2.02	5.39	5.55	1.85	0.17
Synoviocyte, donor2	11368-117I9	26.82	3.35	1.68	1.34	0.50	0.67	0.50	0.84	0.17
Synoviocyte, donor3	11440-118H9	12.06	4.69	0.89	2.46	0.89	0.45	0.45	0.67	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	8.93	3.93	0.00	2.14	0.71	0.36	0.00	0.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	0.00	1.98	1.98	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	4.63	0.46	0.00	1.39	0.00	0.46	0.00	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	3.08	0.79	0.65	0.65	0.22	0.22	0.14	0.22	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	1.16	0.00	0.00	0.77	0.00	0.00	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	0.00	1.15	0.57	0.57	0.57	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	378.79	26.82	12.67	1.72	8.86	5.17	7.38	0.62	0.25
Urethra, donor2	10319-105A4	115.10	12.59	5.40	1.80	1.80	3.60	5.40	0.00	0.00
Urothelial Cells, donor1	11520-119H8	6.11	0.80	0.27	0.80	0.00	0.27	0.80	0.27	0.00
Urothelial Cells, donor2	11600-120H7	0.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	0.23	0.00	0.69	0.46	0.23	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	16.05	2.23	2.23	0.89	0.67	0.89	1.11	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	148.59	23.13	2.67	0.89	0.00	1.78	2.67	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	148.68	28.59	0.00	1.43	1.43	4.29	4.29	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	55.45	8.21	0.68	1.37	0.00	2.05	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	97.10	12.40	1.38	1.38	0.00	1.38	0.34	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	95.87	9.88	0.58	1.74	1.16	0.58	2.32	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	108.29	27.07	2.08	0.00	0.00	0.00	3.12	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	156.02	26.62	2.75	2.75	0.00	1.84	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	47.47	7.30	1.83	0.00	0.91	0.91	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	5.67	1.48	1.60	2.71	0.62	0.37	0.00	0.49	0.25
Wilms' tumor cell line:HFWT	10597-108E3	0.88	0.00	0.00	0.88	0.00	0.88	0.00	1.76	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	51.12	9.22	0.84	0.56	0.56	1.12	0.84	0.28	0.00
achilles tendon, donor2	10292-104G4	51.66	22.73	0.00	2.07	0.00	4.13	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	39.01	5.10	2.29	3.82	1.53	0.25	0.76	0.25	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	16.25	2.79	1.16	1.86	0.93	0.00	0.70	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	19.82	4.15	0.36	2.02	0.59	0.24	0.24	0.95	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	6.53	2.18	1.36	1.36	1.09	0.27	0.27	0.27	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	12.37	3.37	1.12	3.37	0.28	0.84	0.28	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	7.61	1.48	1.06	5.71	1.06	0.42	0.63	1.06	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	28.85	5.17	4.63	2.72	0.54	1.09	0.82	1.63	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	14.54	2.20	0.88	5.29	0.44	0.00	0.44	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	5.72	1.63	1.23	6.13	0.41	0.00	0.41	1.23	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	18.25	1.94	1.55	1.16	0.39	0.39	0.39	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.55	0.74	0.92	1.66	0.74	0.18	0.18	0.55	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	3.90	0.00	0.00	7.80	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	4.18	3.25	1.16	2.79	1.39	0.23	0.23	0.93	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	2.33	1.81	3.37	1.81	0.26	0.26	0.52	0.78	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	4.38	0.88	1.75	3.80	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	8.83	0.46	1.39	2.79	0.00	0.00	0.46	1.39	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	9.46	2.06	0.82	0.41	0.00	0.00	0.82	0.82	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	0.31	0.92	0.00	0.31	0.31	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	1.71	1.71	0.85	1.71	0.85	0.43	0.00	0.85	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	6.98	1.21	1.82	1.52	1.21	0.30	0.00	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	8.18	2.17	0.96	1.44	1.44	0.72	0.72	0.24	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	1.11	0.45	0.67	1.34	0.45	0.00	0.22	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	16.34	2.67	1.00	3.67	0.67	0.00	0.33	1.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	33.45	3.72	1.86	1.86	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	14.31	4.14	1.51	1.51	0.38	0.38	0.38	0.00	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	5.23	4.80	0.44	5.23	0.44	0.44	0.44	0.87	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	33.74	7.50	5.62	0.00	0.00	0.00	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	16.01	3.53	1.41	1.88	0.24	0.24	0.71	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	113.55	17.06	4.50	2.02	5.43	4.03	4.03	0.16	0.16
adipose, donor1	10184-103D4	31.67	15.25	11.73	16.42	12.31	15.25	2.93	3.52	1.17
adipose, donor2	10185-103D5	4.46	1.62	1.22	2.03	2.03	1.62	0.41	0.41	0.41
adipose, donor3	10186-103D6	8.17	2.45	0.54	4.63	1.09	1.63	0.27	1.63	1.09
adipose, donor4	10187-103D7	0.87	2.60	2.60	11.27	1.73	1.73	0.87	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	3.16	1.58	0.63	5.52	0.63	0.79	0.47	1.58	0.47
adrenal gland, adult, pool1	10081-102A9	18.19	14.55	7.28	0.00	3.64	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	4.94	1.20	2.00	2.13	1.07	0.00	0.00	1.07	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	108.98	15.01	3.93	2.14	2.14	0.36	0.71	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	178.76	15.77	10.20	1.62	9.27	2.09	0.93	1.39	0.00
amniotic membrane cells, donor2	12236-129G4	18.60	5.07	0.68	2.03	2.70	2.03	0.68	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	94.86	13.55	9.43	2.36	7.07	2.36	1.77	0.29	0.29
amygdala - adult, donor10196	10167-103B5	83.01	32.02	5.93	1.19	15.42	14.23	7.11	3.56	0.00
amygdala, adult, donor10252	10151-102I7	102.40	26.97	7.71	4.06	20.89	27.58	8.11	1.22	0.00
amygdala, newborn, donor10223	10360-105E9	210.12	23.24	4.20	3.55	3.87	3.87	9.36	1.61	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	85.82	10.31	2.16	1.53	1.66	2.55	1.02	0.00	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.66	0.44	1.76	2.21	1.10	0.22	0.00	0.22	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	0.00	0.00	0.00	4.01	0.33	0.00	0.00	1.00	0.67
aorta, adult, pool1	10052-101G7	140.63	35.50	2.94	4.71	2.55	4.51	2.75	1.18	0.20
appendix, adult	10189-103D9	51.23	4.66	2.72	2.72	2.72	1.94	0.78	1.16	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	8.94	2.75	5.50	3.10	6.88	1.38	0.34	2.41	0.69
artery, adult	10190-103E1	141.30	16.30	8.15	2.72	17.66	2.72	4.08	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	11.01	2.03	5.36	3.77	2.61	2.75	0.72	1.59	0.00
b cell line:RPMI1788	10427-106D4	54.28	9.52	0.45	1.49	0.45	0.59	0.45	0.15	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	266.63	26.63	7.21	1.39	2.77	4.16	1.39	1.66	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	4.56	0.40	1.89	0.99	1.19	0.10	0.10	0.40	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	34.98	2.18	3.85	0.84	1.51	1.34	0.17	0.67	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	2.80	2.24	1.12	1.12	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	110.49	16.51	4.02	2.39	5.87	6.30	2.93	0.43	0.11
blood, adult, pool1	10053-101G8	8.86	4.43	0.00	2.21	0.00	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	763.01	66.80	5.99	4.28	1.71	3.43	3.43	0.86	0.00
bone marrow, adult	10192-103E3	59.38	6.75	1.35	3.37	0.67	1.35	2.70	0.67	0.00
brain, adult, donor1	10084-102B3	10.25	7.18	0.00	3.08	3.08	2.05	2.05	0.00	0.00
brain, adult, pool1	10012-101C3	37.64	21.60	4.79	3.12	8.69	13.81	6.46	1.45	0.00
brain, fetal, pool1	10085-102B4	2.67	0.00	0.00	8.01	0.00	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	1.32	0.33	0.00	0.66	1.32	0.33	0.00	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	3.00	0.37	0.12	0.62	0.50	0.00	0.12	0.12	0.00
breast, adult, donor1	10080-102A8	66.29	13.89	7.58	1.89	2.53	1.89	1.89	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	10.16	0.38	0.51	0.51	0.89	0.00	0.38	0.51	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	38.34	7.11	0.62	0.93	0.00	1.55	0.62	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	44.89	6.22	1.38	2.07	1.61	0.46	0.92	0.69	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	13.56	4.12	0.24	2.18	0.48	1.21	0.24	1.69	0.00
carcinoid cell line:NCI-H1770	10703-109H1	1.41	0.00	2.35	10.34	3.29	0.47	0.00	1.88	0.47
carcinoid cell line:NCI-H727	10735-110B6	0.77	0.22	1.20	0.66	0.33	0.11	0.11	0.11	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	44.37	9.19	0.95	15.21	2.22	1.27	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	12.51	2.93	2.40	7.45	1.86	0.53	0.80	0.27	0.53
caudate nucleus - adult, donor10196	10177-103C6	85.20	35.69	4.61	3.45	17.27	19.57	16.12	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	92.53	28.28	8.70	8.87	18.57	22.25	8.70	1.67	0.50
caudate nucleus, adult, donor10258	10379-105H1	42.03	11.46	4.58	7.64	7.64	7.64	9.17	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	329.24	19.41	6.23	3.30	3.66	7.69	8.42	0.73	0.37
cerebellum - adult, donor10196	10173-103C2	81.57	29.13	8.74	0.00	43.70	29.13	5.83	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	156.93	40.57	14.73	2.56	40.35	52.95	8.11	0.85	0.21
cerebellum, adult, pool1	10083-102B2	14.83	8.97	2.41	2.76	5.17	7.59	0.69	1.03	0.34
cerebellum, newborn, donor10223	10357-105E6	48.16	12.45	8.30	6.64	4.98	4.98	3.32	0.83	1.66
cerebral meninges, adult	10188-103D8	108.17	33.28	4.79	5.04	8.07	12.61	8.07	1.76	0.25
cerebrospinal fluid, donor2	10294-104G6	112.56	16.08	3.65	0.73	8.04	3.65	2.19	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	34.80	6.76	4.74	3.59	2.73	2.73	0.72	0.58	0.14
cervical cancer cell line:ME-180	10553-107I4	0.17	0.00	1.99	1.16	0.99	0.00	0.00	0.50	0.00
cervix, adult, pool1	10013-101C4	94.18	15.12	4.30	3.46	5.98	7.45	3.36	0.31	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	72.04	8.08	1.67	1.67	1.39	1.25	0.98	0.14	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	594.35	48.33	5.23	2.61	0.00	2.61	1.31	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	12.55	2.36	0.50	2.24	0.99	0.37	0.25	1.24	0.25
choriocarcinoma cell line:SCH	10785-110H2	9.12	0.99	1.11	0.74	0.25	0.25	0.25	0.49	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	9.49	1.66	0.71	1.66	1.42	0.24	0.24	0.47	0.00
chorionic membrane cells, donor1	12238-129G6	91.17	9.12	4.27	2.85	3.70	1.42	1.99	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	82.43	10.04	3.28	2.49	3.28	1.59	1.39	0.50	0.40
chorionic membrane cells, donor3	12240-129G8	102.20	10.99	4.95	2.20	3.85	2.20	0.55	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	3.03	0.00	1.01	1.01	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	17.29	1.92	1.15	1.15	0.58	0.00	0.19	0.58	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	10.77	3.17	2.11	2.11	0.84	0.84	0.21	0.84	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	42.89	7.19	1.03	1.54	1.54	0.77	1.03	1.03	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	41.84	5.08	1.94	3.63	1.21	0.73	0.73	0.00	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	39.30	4.68	2.24	2.04	1.43	1.63	0.00	0.61	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	68.31	12.37	3.24	0.00	1.47	1.77	1.77	0.59	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	23.20	5.99	4.43	5.21	1.30	0.78	0.52	3.91	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	21.94	4.80	1.14	0.69	0.46	1.14	0.46	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	41.64	7.81	1.21	1.04	0.52	1.74	1.04	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	2.20	0.92	0.73	0.18	0.73	0.18	0.18	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	35.73	7.98	1.14	1.52	0.38	1.52	0.38	0.76	0.00
colon, adult, donor1	10082-102B1	5.95	1.19	2.38	1.19	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	62.04	6.93	5.17	1.53	3.76	2.47	1.76	0.59	0.35
colon, fetal, donor1	10070-101I7	74.16	5.56	0.62	2.47	2.47	1.24	0.00	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	4.58	0.00	0.00	4.58	4.58	0.00	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	192.07	12.32	11.90	14.87	4.67	0.00	1.70	2.12	6.37
cord blood derived cell line:COBL-a 24h infection	10453-106G3	38.49	4.23	2.26	5.28	2.41	0.45	0.75	1.66	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	34.27	3.95	4.65	5.08	2.54	0.14	0.56	1.41	1.97
corpus callosum, adult, pool1	10042-101F6	38.81	9.51	6.41	5.20	13.38	13.27	7.19	0.66	0.33
cruciate ligament, donor2	10295-104G7	87.53	21.88	2.43	0.81	1.62	1.62	2.43	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	189.40	26.48	9.63	1.61	12.04	2.41	4.01	0.80	0.00
diencephalon, adult	10193-103E4	45.60	19.92	4.08	1.68	8.16	12.96	5.52	1.20	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	6.43	2.07	0.92	4.82	0.69	0.00	0.00	0.23	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	13.33	1.54	1.03	2.05	0.26	1.03	0.51	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	8.43	1.20	0.72	2.41	0.48	0.00	0.00	0.00	0.24
ductus deferens, adult	10196-103E7	50.83	10.47	3.99	1.00	4.49	2.49	4.49	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	60.49	14.40	2.88	5.76	1.44	2.88	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	95.63	8.83	3.68	2.94	4.41	0.00	2.21	1.47	0.74
dura mater, adult, donor1	10041-101F5	82.09	20.40	1.65	1.98	1.16	3.39	2.56	0.50	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	18.88	0.89	7.33	0.89	1.11	0.67	0.22	0.67	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	6.16	1.15	4.30	0.72	1.43	0.14	0.00	0.72	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	14.18	1.85	0.00	1.85	0.62	1.23	0.62	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	10.90	2.42	0.61	3.03	0.61	1.82	0.61	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	19.14	4.01	2.16	2.78	0.93	2.16	0.31	0.62	0.31
embryonic pancreas cell line:2C6	10603-108E9	18.39	1.31	1.31	1.31	0.00	2.63	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	54.30	8.04	3.02	1.01	4.36	3.02	1.01	0.67	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	50.20	7.25	4.17	4.89	1.63	1.09	1.45	3.44	2.17
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	7.40	1.77	0.64	1.29	0.80	0.32	0.80	0.16	0.00
epidermoid carcinoma cell line:A431	10426-106D3	28.57	4.89	1.11	1.45	0.33	0.44	0.44	0.11	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	32.89	4.07	1.65	0.99	0.66	0.44	0.22	0.66	0.33
epididymis, adult	10197-103E8	60.07	8.79	3.56	2.09	1.26	2.72	1.47	0.42	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	42.22	7.10	3.19	3.90	0.89	0.71	0.89	0.71	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	32.25	1.97	2.36	0.79	0.00	0.00	0.39	0.79	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	48.10	6.81	5.90	1.83	4.72	1.57	0.66	0.79	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	29.13	3.35	3.84	1.97	3.44	0.69	0.59	0.79	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	33.94	7.17	3.36	1.90	3.25	1.01	0.78	1.01	0.22
esophagus, adult, pool1	10015-101C6	130.39	13.38	4.67	1.91	4.14	5.42	2.02	0.42	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	1.00	0.38	1.63	6.26	0.75	0.38	0.38	1.25	0.38
eye - muscle inferior rectus, donor1	10272-104E2	118.31	12.07	0.00	4.83	2.41	7.24	7.24	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	206.21	23.15	4.21	0.00	16.83	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	114.59	4.46	4.46	5.95	4.46	2.98	4.46	1.49	0.00
eye - muscle superior, donor2	10297-104G9	116.94	20.64	2.29	1.15	9.17	2.29	3.44	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	20.40	5.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	47.80	8.64	2.54	3.05	6.36	11.19	2.54	1.02	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	6.15	2.18	0.64	0.77	0.13	0.38	0.00	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	25.17	4.75	2.61	4.51	2.14	0.95	0.95	1.66	0.00
frontal lobe, adult, pool1	10040-101F4	40.34	22.80	6.29	10.41	14.64	16.51	9.29	2.35	0.75
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	41.73	4.20	9.91	7.21	3.90	1.20	0.30	1.80	2.10
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	153.16	21.58	2.74	4.48	2.10	7.77	1.65	0.82	0.27
gall bladder, adult	10198-103E9	33.80	4.35	2.66	2.66	1.69	0.97	0.97	0.48	0.00
gamma delta positive T cells, donor1	11937-126A2	11.81	3.76	2.68	3.22	0.54	1.07	0.54	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	6.35	3.36	3.36	3.73	0.00	0.37	0.75	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	29.78	3.59	4.44	3.59	2.53	0.63	0.42	1.48	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	2.51	0.58	0.97	1.74	0.39	0.58	0.19	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	2.30	2.13	1.48	2.95	0.82	0.82	0.33	1.15	0.16
gastric cancer cell line:GSS	10560-108A2	6.41	2.75	0.92	0.00	1.83	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	0.69	0.23	7.08	4.11	6.63	0.00	0.00	0.69	0.69
giant cell carcinoma cell line:LU65	10487-107B1	6.31	3.10	1.61	1.72	1.15	2.98	0.46	1.49	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	105.81	11.06	1.96	0.70	0.70	1.68	0.28	0.14	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	45.89	6.98	3.99	1.75	2.99	1.25	0.25	1.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	45.28	5.38	0.21	1.69	0.32	0.63	0.53	0.42	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	46.34	7.30	1.12	1.12	0.42	0.70	0.70	0.14	0.56
glioblastoma cell line:T98G	10485-107A8	184.76	11.59	2.87	4.86	1.43	1.55	0.99	0.66	0.33
glioma cell line:GI-1	10413-106B8	10.54	2.93	3.81	2.05	1.17	0.29	0.00	1.76	0.00
globus pallidus - adult, donor10196	10175-103C4	67.79	22.60	5.83	2.92	10.20	17.49	15.31	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	120.83	23.92	7.08	3.66	31.73	26.85	16.35	0.73	0.00
globus pallidus, adult, donor10258	10367-105F7	28.75	6.85	2.74	1.37	9.58	4.11	10.95	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	112.45	9.06	4.80	1.07	4.26	2.13	2.66	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	0.00	0.00	2.45	9.79	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	59.52	11.84	1.60	1.28	0.00	0.64	0.32	1.28	0.32
hIPS +CCl2, biol_rep1	14383-156B9	2.30	1.84	3.67	5.05	1.84	0.00	1.84	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	0.46	0.91	0.91	4.12	2.74	0.91	1.37	0.00	2.29
hIPS +CCl2, biol_rep3	14385-156C2	1.29	0.00	0.00	3.86	1.29	1.29	0.64	0.00	2.58
hIPS, biol_rep1	14380-156B6	1.44	1.44	0.00	5.75	1.44	1.44	2.87	0.00	2.87
hIPS, biol_rep2	14381-156B7	0.69	0.69	0.69	2.06	0.69	0.69	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	30.90	15.45	4.41	8.83	5.52	13.24	7.72	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	8.62	3.74	0.57	1.15	1.15	0.00	0.29	0.00	0.57
heart - mitral valve, adult	10205-103F7	243.06	23.32	8.97	2.09	11.66	4.48	4.19	0.90	0.00
heart - pulmonic valve, adult	10206-103F8	125.51	19.61	9.15	3.40	11.24	4.97	2.35	0.78	0.00
heart - tricuspid valve, adult	10207-103F9	204.83	16.65	6.66	1.67	9.99	5.00	11.66	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	34.49	6.94	1.84	2.45	3.67	0.82	0.41	0.41	0.20
heart, adult, diseased, donor1	10051-101G6	64.73	9.79	2.13	0.43	5.11	0.85	0.85	0.00	0.00
heart, adult, pool1	10016-101C7	237.34	22.31	8.05	0.46	15.87	4.83	1.84	0.23	0.00
heart, fetal, pool1	10046-101G1	163.16	18.89	11.81	2.88	17.76	14.48	2.05	0.82	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	143.46	14.19	2.78	3.09	0.62	1.54	0.62	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	30.92	4.76	3.57	0.00	9.51	2.38	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	5.86	2.43	2.32	2.65	1.88	0.55	0.66	0.55	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	7.28	3.03	2.43	2.55	2.31	0.85	0.24	0.85	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	6.47	3.94	2.22	2.43	2.53	1.41	0.40	1.62	0.10
hepatoma cell line:Li-7	10484-107A7	43.37	4.45	7.23	1.56	2.56	1.45	0.89	1.89	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	11.16	4.02	0.70	1.51	0.40	0.30	0.30	0.30	0.50
hippocampus - adult, donor10196	10169-103B7	87.06	34.07	4.73	10.41	12.30	11.36	10.41	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	99.60	31.64	10.82	5.51	27.96	30.41	12.65	1.43	0.20
hippocampus, adult, donor10258	10374-105G5	18.42	13.94	3.49	2.99	6.47	4.48	7.47	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	155.80	17.98	3.52	2.11	3.52	3.88	2.82	1.06	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	2.44	1.22	3.05	11.60	2.44	1.83	0.00	1.83	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	0.79	0.59	1.96	3.73	1.37	0.79	0.00	1.18	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	0.51	1.27	1.02	6.35	2.54	1.27	0.25	0.51	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	2.82	2.26	3.95	6.20	1.69	3.38	0.56	1.13	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	3.61	3.10	4.39	8.78	5.42	6.46	0.52	1.03	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	3.04	1.52	5.31	8.73	5.69	3.80	0.76	3.04	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	10.22	3.50	3.21	8.47	1.75	3.80	2.04	3.21	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	8.40	2.37	3.23	5.17	4.31	4.09	0.65	1.94	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	10.43	2.50	2.09	4.59	2.50	2.09	0.42	1.25	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	8.29	2.60	3.32	3.32	3.79	2.60	0.95	3.08	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	7.23	1.13	1.77	2.25	1.77	0.80	0.16	1.77	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	10.10	3.37	5.39	6.06	2.02	0.00	0.00	4.04	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	1.10	1.88	1.88	3.44	2.19	0.63	0.31	0.78	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	3.93	1.47	0.49	8.35	0.49	1.47	0.00	0.49	2.95
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	7.85	0.00	5.24	3.49	3.49	3.49	0.87	1.75	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	7.06	2.86	4.58	6.11	3.82	3.44	1.15	3.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	5.67	3.92	3.49	3.92	2.62	1.74	0.87	2.18	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	14.99	5.00	4.00	6.50	4.00	4.50	2.50	3.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	8.67	2.07	1.51	1.51	0.94	7.54	0.94	0.57	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	13.64	2.27	0.91	1.36	1.82	4.09	0.91	1.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	8.14	1.88	0.31	3.13	2.51	4.39	0.94	1.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	8.65	2.61	1.47	2.29	2.29	1.14	0.49	0.49	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	6.10	3.77	2.03	2.03	1.45	1.74	0.29	1.74	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	8.07	2.09	0.60	2.99	0.30	1.20	0.30	1.20	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	2.96	0.55	2.03	5.54	1.85	0.92	0.18	0.74	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	0.86	0.29	1.43	5.99	0.29	0.00	0.00	0.00	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	5.31	1.63	2.04	11.02	1.22	0.82	0.82	2.45	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	6.69	1.41	1.41	6.69	3.17	1.76	2.46	1.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	1.90	1.58	1.58	7.92	1.58	1.58	0.00	1.27	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	4.84	2.12	3.33	5.75	0.91	3.33	0.00	1.82	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	17.58	2.59	0.52	7.24	2.07	0.52	0.00	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	12.62	1.33	1.99	3.32	1.33	1.33	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	8.21	1.28	1.54	3.85	1.54	2.31	0.77	2.31	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	13.55	3.83	1.28	3.07	1.53	0.77	0.51	0.77	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	12.87	3.03	3.03	5.30	0.00	2.27	0.76	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	16.80	2.35	2.69	2.35	1.68	1.34	1.01	2.35	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	0.72	0.48	1.45	7.97	1.45	0.97	0.24	0.72	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	0.89	2.67	2.67	10.70	2.23	1.34	0.45	0.00	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	1.95	0.98	0.98	5.85	2.44	0.49	0.00	1.46	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	2.44	1.83	2.75	6.11	3.67	0.92	0.31	1.22	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	45.55	32.53	48.80	84.58	29.28	29.28	3.25	65.06	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	5.96	1.65	8.27	15.55	4.63	0.99	0.33	3.31	1.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	9.85	1.09	3.28	3.83	0.00	1.09	0.55	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	5.79	1.09	1.09	3.26	2.17	3.62	0.72	1.81	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	7.47	1.78	3.20	3.20	2.49	2.85	0.71	1.42	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	3.58	1.19	1.19	7.16	1.19	1.19	2.39	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	9.62	4.06	6.23	6.77	2.84	2.71	0.68	1.90	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	6.73	0.54	2.16	6.73	1.35	1.08	0.54	0.81	0.54
immature langerhans cells, donor1	11904-125F5	66.59	12.59	1.70	0.24	0.73	0.97	1.70	0.24	0.00
immature langerhans cells, donor2	11905-125F6	148.13	14.26	1.58	0.79	0.00	0.00	0.79	0.79	0.00
insula, adult, pool1	10039-101F3	37.57	16.94	5.49	8.61	10.32	9.37	7.00	1.80	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	7.15	3.25	1.30	1.95	0.33	0.33	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	50.76	8.11	5.41	2.90	5.41	3.40	2.70	0.90	0.00
kidney, fetal, pool1	10045-101F9	35.65	3.75	2.41	3.18	2.97	1.70	0.92	0.28	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	15.05	4.26	4.12	6.25	2.56	0.85	0.43	2.56	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	13.13	1.94	1.80	0.55	0.55	0.28	0.00	0.00	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	30.83	3.30	2.94	2.39	1.65	1.10	0.37	0.18	0.00
left atrium, adult, donor1	10079-102A7	31.60	9.26	3.81	1.09	6.54	2.72	0.54	0.00	0.54
left ventricle, adult, donor1	10078-102A6	73.83	21.74	4.05	0.51	10.62	4.55	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	17.51	4.92	1.09	3.01	0.27	0.27	0.00	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	30.54	3.23	1.08	1.80	0.36	1.08	0.36	0.00	0.36
leiomyoma cell line:15242A	10570-108B3	85.87	8.70	2.72	0.54	1.63	2.17	1.63	0.54	0.00
leiomyoma cell line:15425	10571-108B4	36.67	5.83	1.46	1.94	0.73	0.97	0.24	0.73	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	101.59	6.35	12.70	6.35	0.00	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	72.14	11.50	6.27	8.36	2.09	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	68.47	14.05	3.19	3.54	0.94	0.71	0.24	0.83	0.71
liposarcoma cell line:KMLS-1	10782-110G8	481.13	33.43	5.47	16.40	1.41	4.69	3.75	2.19	6.56
liposarcoma cell line:SW 872	10726-110A6	21.32	4.26	2.68	0.85	2.68	0.73	0.61	0.24	0.24
liver, adult, pool1	10018-101C9	29.50	4.21	1.62	0.49	1.78	1.62	0.49	0.16	0.00
liver, fetal, pool1	10086-102B5	23.52	12.23	0.94	0.00	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	79.18	25.81	6.12	3.35	12.69	15.89	15.46	1.02	0.29
locus coeruleus, adult, donor10252	10165-103B3	132.88	31.56	11.26	2.95	25.84	27.31	9.23	1.11	0.00
locus coeruleus, adult, donor10258	10375-105G6	26.52	11.00	3.10	2.82	5.64	7.34	6.77	0.85	0.28
locus coeruleus, newborn, donor10223	10362-105F2	169.93	10.52	7.99	6.31	10.94	8.83	6.73	0.84	1.26
lung adenocarcinoma cell line:A549	10499-107C4	32.94	3.04	2.35	0.55	1.11	0.28	0.42	0.69	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	53.08	8.27	0.69	2.07	1.38	1.38	1.38	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	10.02	3.30	0.79	0.53	0.00	1.05	0.53	0.13	0.13
lung, adult, pool1	10019-101D1	152.15	15.00	4.13	2.36	5.55	4.73	3.31	0.71	0.00
lung, fetal, donor1	10068-101I5	559.40	50.52	13.13	6.56	13.70	5.99	10.27	1.43	0.86
lung, right lower lobe, adult, donor1	10075-102A3	75.15	12.83	2.29	1.37	1.83	1.37	1.37	0.92	0.00
lymph node, adult, donor1	10077-102A5	15.62	5.21	0.47	0.00	0.00	1.42	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	8.11	1.97	0.22	0.88	0.66	0.00	0.00	0.44	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	47.54	8.00	0.30	2.11	0.75	0.30	0.91	0.45	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	65.41	10.19	5.95	0.00	1.70	0.00	1.70	1.70	0.00
mature adipocyte, donor1	12231-129F8	279.27	40.85	3.11	3.11	3.11	7.99	7.55	0.89	0.00
mature adipocyte, donor2	12232-129F9	233.05	31.13	5.60	1.45	4.98	12.66	8.30	0.83	0.00
mature adipocyte, donor3	12233-129G1	234.69	25.37	4.74	1.19	3.32	6.16	5.93	0.24	0.24
mature adipocyte, donor4	12234-129G2	341.13	36.59	3.95	2.37	3.95	6.58	5.00	2.37	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	55.75	14.77	3.34	8.10	1.19	4.77	1.67	0.95	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	53.02	27.07	9.02	3.38	22.56	18.05	18.05	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	116.60	39.36	13.61	4.78	25.20	26.85	10.11	1.29	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	23.83	21.60	5.40	3.49	6.04	11.44	10.48	1.27	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	587.27	57.58	18.77	8.96	11.52	9.38	14.07	6.82	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	75.60	40.33	9.45	4.89	16.37	22.78	12.66	2.19	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	101.66	30.98	9.76	4.24	24.62	26.53	10.82	1.06	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	19.26	13.48	3.85	3.85	0.00	9.63	3.85	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	401.90	488.02	71.77	86.12	143.54	100.48	100.48	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	152.91	14.36	2.87	5.38	5.38	1.44	3.23	1.79	0.72
medulla oblongata - adult, donor10196	10174-103C3	72.69	18.17	5.19	3.89	12.98	18.82	19.47	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	139.63	31.89	11.77	2.63	25.54	23.99	11.77	0.62	0.15
medulla oblongata, adult, pool1	10038-101F2	37.06	13.47	4.82	4.90	9.55	12.73	8.24	0.57	0.08
medulla oblongata, newborn, donor10223	10361-105F1	86.45	9.72	8.68	1.74	6.94	7.99	6.60	0.35	0.69
medulloblastoma cell line:D283 Med	10838-111E1	51.15	15.50	5.09	9.52	0.66	3.99	0.44	1.99	0.22
medulloblastoma cell line:ONS-76	10759-110E3	7.70	4.28	1.22	2.93	0.98	1.10	0.49	0.61	0.37
melanoma cell line:COLO 679	10514-107E1	10.35	2.01	2.16	1.01	0.43	0.43	0.00	0.43	0.29
melanoma cell line:G-361	10465-106H6	5.16	1.09	0.27	5.16	0.81	0.81	0.54	0.81	0.81
meningioma cell line:HKBMM	10691-109F7	14.83	1.27	1.81	0.90	0.18	0.54	0.00	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	3.52	2.64	1.76	12.34	0.88	0.00	0.00	1.76	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	0.00	0.00	4.41	11.92	3.37	0.00	0.00	2.59	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	71.96	11.97	1.69	1.84	0.92	1.23	1.38	1.07	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	32.54	5.64	2.36	2.54	1.09	0.73	0.00	0.36	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	63.36	10.77	2.07	3.31	0.83	0.83	1.24	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	33.29	6.32	2.11	1.69	2.25	0.98	0.28	0.42	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	33.89	6.16	2.12	3.85	1.93	0.39	1.16	0.77	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	109.66	22.21	4.16	4.86	3.47	2.08	2.78	0.00	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	56.47	7.55	3.09	4.46	2.06	1.54	0.34	1.20	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	104.89	13.34	4.26	3.34	2.88	1.27	1.15	0.81	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	28.12	8.62	2.39	3.32	1.06	1.46	0.40	0.40	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	46.18	7.70	0.95	2.30	0.81	0.81	0.81	0.54	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	46.38	8.39	5.41	1.56	1.71	1.00	0.14	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	18.11	2.96	3.95	2.31	0.99	0.66	1.32	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	40.54	6.78	3.04	1.66	0.69	0.55	0.28	0.97	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	26.53	8.38	2.79	2.44	0.70	0.35	1.40	1.05	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	144.14	18.37	3.27	4.08	1.22	2.86	1.02	0.82	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	94.18	8.63	2.88	1.08	1.08	1.80	0.00	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	32.28	4.24	1.66	1.97	0.72	0.10	0.31	0.10	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	142.95	11.17	1.82	2.05	0.68	1.37	0.91	1.14	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	157.33	18.46	5.45	7.13	2.52	2.10	1.26	0.42	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	37.51	6.28	1.49	4.33	1.79	0.30	0.45	0.60	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	20.48	4.29	2.63	1.14	1.49	0.61	0.18	0.79	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	68.48	10.68	6.63	4.79	2.58	0.37	0.74	1.47	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	128.48	14.59	2.29	3.15	0.29	0.57	1.43	1.14	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	690.88	39.58	8.42	7.58	2.11	8.42	2.95	4.63	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	15.53	4.11	0.91	3.20	1.83	0.00	0.46	0.91	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	32.48	4.60	1.28	0.77	0.77	0.51	0.51	1.53	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	24.08	6.02	2.36	1.83	1.05	0.52	0.26	1.31	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	19.72	4.31	1.23	5.24	0.62	0.00	0.00	0.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	36.72	4.24	1.41	1.65	1.41	0.71	1.18	1.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	21.66	6.09	2.03	1.69	0.34	0.68	0.00	1.35	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	23.19	2.75	0.39	1.18	0.39	0.39	0.79	1.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	22.71	1.39	2.78	1.39	0.46	1.39	0.00	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	38.94	9.52	2.02	2.31	0.58	0.87	0.87	1.73	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	24.09	5.13	2.01	1.56	0.22	0.89	0.67	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	20.91	4.81	1.20	1.44	0.72	1.20	0.48	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	46.93	12.47	0.73	1.47	0.00	2.20	0.00	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	24.50	3.36	0.67	2.01	1.01	1.01	0.34	1.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	27.43	8.60	1.64	2.87	1.23	0.82	0.41	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	21.91	6.44	1.72	2.15	0.86	0.43	0.43	1.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	27.34	5.47	0.00	0.00	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	0.00	5.16	5.16	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	20.14	5.85	1.30	2.60	1.62	0.65	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	24.73	8.73	1.45	2.91	0.00	0.00	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	26.12	3.73	2.67	0.00	0.00	0.00	1.07	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	29.44	4.91	0.00	3.27	1.64	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	21.77	4.28	1.55	1.17	0.78	0.00	0.78	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	0.00	0.00	2.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	18.88	4.97	1.99	1.99	0.00	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	4.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	25.50	5.34	1.78	2.37	0.00	1.19	0.59	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	26.81	0.00	0.00	1.22	0.00	0.00	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	34.20	6.33	1.90	1.90	0.63	1.90	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	29.32	6.21	1.38	1.38	1.38	0.34	1.03	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	21.49	4.30	0.00	4.30	4.30	2.15	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	7.98	3.99	0.00	7.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	13.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	18.74	2.44	3.67	4.07	0.41	0.00	0.00	0.41	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	22.24	3.18	3.18	2.38	0.79	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	20.63	2.36	2.36	4.13	2.36	1.77	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	19.95	3.43	1.56	1.25	1.25	0.00	0.00	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	20.05	5.35	2.67	2.67	1.34	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	11.83	3.55	1.18	1.18	1.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	10.27	5.14	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	15.14	4.82	0.69	0.69	0.69	0.00	1.38	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	8.41	2.47	4.45	0.49	0.99	0.49	0.99	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	1.12	3.36	0.00	0.00	0.00	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	7.63	3.18	2.54	3.18	1.91	1.27	1.27	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	4.43	3.22	2.82	0.00	0.40	0.40	0.00	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	4.36	4.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1.27	1.27	1.27	0.00	0.00	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	16.99	3.03	3.64	0.61	3.03	1.21	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	4.52	4.52	0.00	4.52	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	18.12	1.65	1.65	0.82	1.65	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	25.60	5.16	1.59	2.38	1.19	0.79	0.40	0.40	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	12.33	2.92	1.62	0.00	1.62	0.65	0.65	1.30	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	20.37	1.02	1.02	0.00	0.00	0.00	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	180.28	23.99	6.19	8.51	2.32	2.32	4.64	3.09	2.32
mesothelioma cell line:ACC-MESO-1	10493-107B7	274.04	30.24	4.72	1.65	2.36	2.83	2.60	1.89	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	107.03	15.29	0.70	1.16	0.93	0.23	1.39	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	68.38	8.55	0.00	4.27	0.00	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	100.90	7.81	1.85	3.70	0.62	0.92	1.23	0.21	0.72
mesothelioma cell line:Mero-25	10850-111F4	2.50	0.45	0.91	0.91	0.23	0.23	0.00	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	44.49	4.89	0.73	1.22	0.24	0.24	0.49	0.00	0.49
mesothelioma cell line:Mero-48a	10852-111F6	84.81	15.94	1.77	1.55	0.22	1.55	0.89	0.00	0.66
mesothelioma cell line:Mero-82	10853-111F7	28.12	1.84	2.63	3.42	2.63	1.05	0.00	1.05	0.00
mesothelioma cell line:Mero-83	10854-111F8	95.32	9.87	1.53	5.96	1.02	1.19	1.70	1.36	1.02
mesothelioma cell line:Mero-84	10855-111F9	5.81	1.26	0.25	0.51	0.00	0.25	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	25.26	4.76	0.83	2.28	1.04	0.00	0.21	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	63.28	5.47	0.66	0.50	0.66	0.17	0.83	0.33	0.00
mesothelioma cell line:NCI-H226	10846-111E9	43.26	6.33	1.81	3.08	0.54	0.72	0.54	0.36	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	31.60	4.10	0.68	0.51	0.17	0.51	0.51	0.68	0.17
mesothelioma cell line:NCI-H28	10845-111E8	77.36	6.62	3.31	5.85	1.02	2.04	2.54	1.27	1.78
mesothelioma cell line:No36	10857-111G2	22.51	4.57	0.98	0.33	0.33	0.98	0.98	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	60.42	6.77	3.52	1.63	0.54	0.54	0.27	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	203.82	42.03	6.33	4.22	6.33	3.45	9.02	0.96	0.38
migratory langerhans cells, donor2	11902-125F3	181.34	21.25	9.16	2.81	5.37	1.59	4.40	0.85	1.10
migratory langerhans cells, donor3	11903-125F4	50.43	18.13	4.67	3.77	3.95	1.08	4.85	0.54	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	20.57	2.61	6.53	1.96	0.98	1.63	0.00	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	65.91	5.30	1.27	0.42	0.85	2.76	0.85	1.27	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	0.92	0.46	0.69	0.69	0.00	0.00	0.00	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	14.08	3.04	0.19	0.38	0.00	0.19	0.95	0.00	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	17.37	4.99	1.29	3.51	1.11	0.37	0.00	1.48	0.55
myeloma cell line:PCM6	10474-106I6	2.37	0.20	1.38	1.98	0.00	0.00	0.00	0.79	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	161.32	16.74	1.01	0.00	1.52	2.03	0.51	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	14.71	4.32	1.77	1.18	0.78	0.39	0.98	0.00	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	4.12	0.78	1.56	0.67	0.45	0.89	0.33	0.45	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	5.81	1.69	2.21	0.96	0.96	1.25	0.15	0.44	0.07
nasal epithelial cells, donor2	12227-129F4	4.97	0.55	0.00	0.00	0.55	0.55	0.55	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	4.14	2.07	6.21	16.56	5.29	0.46	0.23	1.61	0.92
neuroblastoma cell line:NB-1	10539-107G8	6.17	2.43	4.86	11.41	5.24	0.37	0.75	3.18	1.31
neuroblastoma cell line:NBsusSR	10607-108F4	7.38	1.48	0.42	5.69	0.63	0.63	0.21	1.27	0.21
neuroblastoma cell line:NH-12	10555-107I6	4.47	0.93	2.24	9.50	1.30	0.75	0.00	1.12	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	11.15	2.61	1.66	13.28	1.66	0.95	0.95	1.90	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	38.64	3.48	1.58	3.64	0.79	0.63	0.63	1.11	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	6.64	2.62	0.00	3.42	1.61	0.20	0.20	1.01	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	27.34	6.99	0.00	3.18	1.27	0.00	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	150.38	17.30	1.60	1.86	0.80	2.93	1.06	0.80	0.53
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	83.04	10.99	5.07	8.63	6.93	1.86	0.34	1.18	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	41.63	8.01	5.60	2.40	6.40	0.00	0.80	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	38.15	9.30	0.96	3.53	0.96	0.64	0.00	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	19.71	4.73	2.63	1.58	0.00	0.79	0.26	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	51.93	21.56	6.09	7.87	12.47	14.25	8.34	1.87	0.00
occipital cortex - adult, donor10196	10172-103C1	113.32	53.57	14.42	4.12	20.60	24.72	8.24	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	129.35	34.35	12.08	3.49	32.47	23.88	13.15	1.34	0.27
occipital cortex, newborn, donor10223	10355-105E4	176.88	16.38	2.91	5.82	2.91	1.46	2.91	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	36.74	23.35	5.51	3.67	10.23	9.45	6.56	1.84	0.52
occipital lobe, fetal, donor1	10073-102A1	5.58	5.58	2.57	3.00	0.43	0.43	0.43	3.00	0.86
occipital pole, adult, pool1	10036-101E9	10.01	5.91	1.02	2.92	3.39	3.86	2.60	0.55	0.00
olfactory region, adult	10195-103E6	29.61	14.71	2.48	4.59	10.32	11.46	6.88	0.57	0.19
optic nerve, donor1	10277-104E7	42.02	12.01	0.00	2.00	2.00	20.01	6.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	56.61	8.66	2.62	10.94	1.25	2.73	0.91	2.85	1.25
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	44.93	5.08	0.96	2.34	0.69	2.75	0.96	0.14	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	14.73	2.88	2.20	3.22	1.19	0.34	0.34	0.34	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	7.28	2.08	1.96	0.81	0.23	0.12	0.23	0.23	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	35.57	4.70	2.06	2.35	0.88	0.59	0.29	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	5.61	0.93	0.00	3.74	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	80.58	13.15	4.88	2.33	1.70	2.33	0.21	1.27	0.42
ovary, adult, pool1	10020-101D2	64.38	9.43	3.14	2.10	5.07	8.74	3.67	0.87	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	20.72	3.85	2.38	2.57	3.67	0.18	0.18	0.73	0.37
pancreas, adult, donor1	10049-101G4	95.95	13.17	4.70	1.88	3.76	3.76	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	5.31	0.84	0.28	1.12	0.00	0.28	0.56	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	56.90	7.33	3.41	2.56	0.85	1.87	1.36	0.51	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	16.72	2.65	1.99	1.82	1.66	0.83	0.17	0.66	0.00
paracentral gyrus, adult, pool1	10035-101E8	37.71	22.70	7.87	6.22	13.36	10.62	8.05	1.46	0.37
parietal cortex, adult, donor10258	10373-105G4	26.42	13.95	5.14	2.94	4.40	8.81	5.87	2.20	2.20
parietal lobe - adult, donor10196	10171-103B9	49.85	45.14	6.58	3.76	23.51	11.29	14.11	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	143.37	42.76	7.70	3.71	25.94	26.79	15.68	0.86	0.00
parietal lobe, adult, pool1	10034-101E7	33.22	17.01	5.64	3.79	14.01	12.69	6.96	0.79	0.18
parietal lobe, fetal, donor1	10072-101I9	3.88	4.85	1.94	16.49	3.88	2.91	0.97	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	241.89	23.93	4.86	4.11	3.36	4.11	5.61	4.11	0.75
parotid gland, adult	10199-103F1	12.95	2.47	1.23	0.62	1.23	1.85	0.62	0.00	0.00
penis, adult	10200-103F2	125.15	18.80	6.98	1.07	6.45	2.69	2.15	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	54.48	4.46	3.90	3.35	0.74	1.86	1.67	0.19	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	16.03	2.77	0.73	0.00	0.73	1.46	0.87	0.15	0.00
pineal gland - adult, donor10196	10179-103C8	79.98	29.03	5.16	10.32	12.90	40.64	5.81	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	259.98	68.70	29.61	17.17	58.63	125.55	16.58	2.37	0.59
pineal gland, adult, donor10258	10377-105G8	31.35	13.80	5.02	7.52	12.54	16.30	3.76	1.88	0.63
pituitary gland - adult, donor10196	10180-103C9	62.73	32.38	7.08	4.05	15.18	17.20	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	134.46	54.72	26.06	10.94	31.79	48.99	9.90	1.56	0.00
pituitary gland, adult, donor10258	10378-105G9	28.09	13.62	4.26	3.40	1.70	3.40	4.26	2.55	0.85
placenta, adult, pool1	10021-101D3	58.27	6.45	2.69	0.75	1.40	1.61	1.61	0.75	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	19.73	5.96	0.79	1.32	0.26	0.93	0.66	0.26	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	78.91	11.98	3.42	5.45	3.11	0.62	0.62	1.87	0.31
pons, adult, pool1	10033-101E6	39.25	17.73	9.38	4.56	20.66	14.20	12.57	1.20	0.43
postcentral gyrus, adult, pool1	10032-101E5	18.66	11.68	2.96	4.27	6.80	7.50	3.14	1.13	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	129.64	10.34	2.91	2.04	1.60	0.87	1.89	1.31	1.31
prostate cancer cell line:PC-3	10439-106E7	17.61	3.09	2.00	1.45	0.91	1.27	0.18	0.00	0.36
prostate, adult, pool1	10022-101D4	96.77	12.88	5.53	2.54	4.63	6.08	3.63	0.73	0.00
putamen, adult, donor10196	10176-103C5	104.34	42.49	6.61	12.98	16.05	21.95	5.43	2.36	1.42
putamen, adult, donor10252	10152-102I8	66.66	27.45	3.92	3.92	11.76	7.84	17.65	3.92	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	32.78	8.74	2.19	5.46	0.00	7.65	5.46	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	31.17	18.12	3.14	7.49	7.97	5.56	4.11	1.21	0.24
putamen, newborn, donor10223	10365-105F5	304.36	28.49	17.99	9.75	10.50	15.74	14.24	2.25	2.25
rectal cancer cell line:TT1TKB	10469-106I1	9.60	1.75	2.91	0.58	1.16	0.87	0.00	1.16	0.00
rectum, fetal, donor1	10067-101I4	11.13	6.95	5.56	11.13	1.39	1.39	0.00	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	37.95	5.94	0.42	0.64	0.64	1.70	1.06	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	40.59	5.38	1.66	9.53	0.41	1.66	2.49	0.41	0.41
retina, adult, pool1	10030-101E3	28.33	8.05	3.58	4.37	6.46	7.06	1.99	0.60	0.60
retinoblastoma cell line:Y79	10475-106I7	1.30	0.78	0.26	15.85	1.04	0.52	0.00	1.56	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	6.39	0.86	0.12	2.95	0.12	0.00	0.00	0.37	0.74
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	88.58	16.87	5.91	2.81	1.12	4.22	1.97	0.28	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	55.32	3.79	1.52	0.76	1.52	0.76	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	14.24	5.50	2.43	3.72	0.16	0.32	0.65	0.49	0.00
salivary acinar cells, donor2	11772-123I8	41.72	8.26	3.44	3.30	1.38	1.10	0.55	0.96	0.28
salivary acinar cells, donor3	11773-123I9	26.48	7.94	5.96	3.97	0.66	1.32	0.00	0.66	0.00
salivary gland, adult, pool1	10093-102C3	30.89	8.01	1.72	1.14	1.14	2.86	1.72	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	8.94	2.70	1.01	1.01	0.25	1.43	0.25	0.34	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	9.40	4.00	1.29	1.18	0.24	1.06	0.24	0.47	0.00
seminal vesicle, adult	10201-103F3	56.08	6.35	2.12	0.53	1.06	2.65	3.70	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	45.43	14.58	2.43	3.89	0.49	2.92	1.46	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	3.27	1.26	1.51	1.26	0.75	0.00	0.00	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	5.02	0.00	1.00	3.01	1.00	0.00	1.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	0.13	0.00	0.40	1.75	1.21	0.00	0.13	0.81	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	1.55	0.33	0.88	1.66	0.11	0.00	0.22	0.66	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	15.74	2.06	1.81	1.68	0.52	0.00	1.03	0.26	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	133.35	24.83	4.97	0.00	4.26	6.38	2.84	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	188.66	16.43	5.64	0.72	7.80	4.92	1.80	0.84	0.00
skeletal muscle, fetal, donor1	10066-101I3	46.23	10.05	1.01	0.00	2.01	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	13.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	99.10	15.15	5.68	6.94	2.52	1.89	1.89	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	0.00	0.00	2.33	1.33	1.33	0.00	0.00	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	3.15	0.63	2.84	8.20	2.52	0.00	0.00	1.26	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	3.28	3.08	2.12	3.08	4.05	1.35	0.19	0.96	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	26.04	4.78	5.11	3.79	2.14	0.82	0.33	1.65	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	8.85	3.22	1.61	3.86	1.45	3.70	0.00	0.80	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	0.22	0.00	3.70	3.70	1.09	0.00	0.00	0.87	0.44
small intestine, adult, pool1	10024-101D6	37.51	6.69	4.18	0.84	2.99	1.31	1.79	0.72	0.12
small intestine, fetal, donor1	10064-101I1	16.46	5.65	1.47	1.47	1.47	1.47	0.49	0.98	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	17.44	4.62	2.05	0.00	1.03	1.54	0.00	0.00	1.03
smooth muscle, adult, pool1	10048-101G3	104.42	17.06	4.39	2.58	4.65	3.88	2.58	1.55	0.52
somatostatinoma cell line:QGP-1	10781-110G7	4.82	4.29	0.54	0.54	0.54	1.61	0.27	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	141.77	35.10	6.42	3.21	18.81	20.19	13.76	1.15	0.23
spinal cord, adult, donor10252	10159-103A6	189.25	39.03	13.41	3.55	34.30	27.60	14.59	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	77.48	31.13	7.61	6.23	6.23	24.90	13.84	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	30.49	13.42	9.15	4.88	12.20	3.66	2.44	2.44	0.61
spinal cord, newborn, donor10223	10359-105E8	152.92	20.21	8.27	2.76	14.24	14.24	10.56	0.92	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	74.23	11.95	2.84	2.84	1.19	1.49	1.19	0.15	0.15
spleen, adult, pool1	10025-101D7	71.15	9.36	2.86	3.08	2.75	3.63	2.97	0.77	0.22
spleen, fetal, pool1	10044-101F8	99.72	8.34	3.02	3.65	2.78	1.19	0.95	0.16	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	49.27	6.11	1.04	0.72	0.62	0.62	0.31	0.41	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	55.06	6.84	1.14	3.61	0.38	1.14	0.38	0.57	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	51.37	8.74	2.45	5.24	1.40	0.70	0.70	1.75	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	8.21	1.17	0.78	0.39	0.00	0.39	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	13.28	4.50	3.15	2.93	1.69	1.35	0.68	1.80	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	91.07	4.24	5.08	5.51	2.54	0.42	1.27	0.85	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	33.42	2.96	2.96	0.00	0.42	0.00	0.85	0.85	0.42
stomach, fetal, donor1	10062-101H8	150.58	33.11	1.07	3.20	0.00	0.00	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	33.61	6.84	3.99	0.00	4.56	1.14	0.57	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	325.64	108.55	0.00	0.00	54.27	217.10	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	149.96	27.21	16.62	3.95	28.66	22.22	12.05	1.04	0.00
substantia nigra, adult, donor10258	10371-105G2	28.97	18.10	6.21	6.21	4.14	15.00	11.90	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	138.49	9.19	4.24	4.24	7.77	3.53	6.36	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	7.11	3.21	3.21	5.50	1.15	0.23	0.00	1.60	0.00
temporal lobe, adult, pool1	10031-101E4	12.55	8.39	1.36	3.39	3.98	4.15	2.80	0.76	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	11.40	4.27	4.99	15.67	2.14	0.71	1.42	3.56	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	7.03	2.20	4.83	9.23	3.08	0.44	0.88	3.52	0.88
tenocyte, donor1	11763-123H8	25.83	4.89	2.44	1.40	1.40	0.35	0.35	0.35	0.00
tenocyte, donor2	11765-123I1	22.89	4.20	3.43	4.96	0.76	0.38	0.00	0.38	0.00
tenocyte, donor3	11768-123I4	74.13	7.41	2.59	2.59	1.48	1.85	1.11	1.11	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	29.23	5.78	8.84	23.96	4.93	0.68	0.34	2.04	4.42
teratocarcinoma cell line:NCR-G1	10798-110I6	5.70	1.54	0.62	2.16	0.62	0.15	0.15	0.15	0.15
teratocarcinoma cell line:PA-1	10807-111A6	4.96	1.39	1.70	3.41	1.55	0.46	0.15	0.00	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	3.55	1.78	14.85	2.92	8.38	0.25	0.38	2.79	2.41
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	1.51	1.51	18.15	14.37	9.08	1.13	0.00	1.89	3.03
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	13.96	3.27	13.85	5.56	4.14	0.44	0.11	1.42	1.09
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2.28	0.00	2.93	2.93	1.95	0.33	0.00	0.65	0.65
testis, adult, pool1	10026-101D8	74.84	10.95	6.55	2.04	4.83	2.58	2.25	1.07	0.00
testis, adult, pool2	10096-102C6	14.89	4.51	6.77	2.71	4.06	0.90	1.35	0.90	0.45
thalamus - adult, donor10196	10168-103B6	82.80	55.20	8.83	2.21	14.35	19.87	13.25	1.10	1.10
thalamus, adult, donor10252	10154-103A1	128.00	25.94	14.22	2.66	30.79	27.82	13.13	0.47	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	46.19	27.71	12.32	0.00	3.08	7.70	7.70	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	21.08	10.38	3.95	1.65	4.61	4.12	3.13	0.82	0.00
thalamus, newborn, donor10223	10366-105F6	501.68	43.15	4.60	5.18	8.05	5.75	7.48	4.60	0.58
throat, adult	10209-103G2	117.10	11.24	7.74	2.75	6.99	3.50	1.00	0.50	0.00
throat, fetal, donor1	10061-101H7	87.76	12.19	4.88	6.09	4.27	2.74	1.22	0.91	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	0.40	0.60	0.20	6.56	0.79	0.00	0.00	0.99	0.40
thymus, adult, pool1	10027-101D9	19.39	3.88	0.30	3.68	1.39	1.09	0.80	1.09	0.20
thymus, fetal, pool1	10043-101F7	189.00	17.35	4.47	9.46	3.53	2.29	2.91	1.04	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	20.74	5.19	1.60	0.66	1.20	0.13	0.13	0.53	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	68.17	9.08	2.79	3.35	2.10	3.07	0.70	0.84	0.42
thyroid, adult, pool1	10028-101E1	140.62	16.61	10.54	3.08	13.25	8.58	3.36	0.75	0.09
thyroid, fetal, donor1	10060-101H6	73.30	18.46	4.75	4.22	4.22	2.90	2.11	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	58.51	12.32	0.00	0.00	3.08	6.16	6.16	0.00	0.00
tongue, adult	10203-103F5	149.78	15.58	5.81	1.16	7.21	2.56	2.33	0.93	0.00
tongue, fetal, donor1	10059-101H5	149.36	18.52	17.34	0.79	15.76	7.49	3.15	0.79	0.00
tonsil, adult, pool1	10047-101G2	29.55	4.81	2.00	2.80	1.90	1.50	0.80	0.60	0.10
trachea, adult, pool1	10029-101E2	72.23	9.98	5.15	2.21	4.91	3.11	1.72	0.57	0.25
trachea, fetal, donor1	10058-101H4	81.94	12.31	3.46	2.69	0.77	2.69	1.15	0.77	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	27.28	1.77	1.42	1.06	0.00	0.35	0.71	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	23.20	2.94	1.82	1.62	1.32	0.71	0.30	1.11	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	31.02	6.11	2.66	5.48	0.78	1.88	1.72	1.57	0.78
tridermal teratoma cell line:HGRT	10694-109G1	104.64	13.32	1.90	1.90	1.90	1.90	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	6.52	0.85	1.69	1.10	0.76	0.00	0.00	0.59	0.25
umbilical cord, fetal, donor1	10057-101H3	73.03	10.43	0.00	4.17	4.17	0.00	4.17	2.09	0.00
uterus, adult, pool1	10100-102D1	148.79	20.13	3.07	9.90	5.63	3.92	5.12	0.85	0.34
uterus, fetal, donor1	10055-101H1	59.90	6.66	1.02	4.10	1.54	1.02	0.00	2.05	0.00
vagina, adult	10204-103F6	458.15	42.00	10.34	0.65	12.28	9.05	6.46	0.00	0.00
vein, adult	10191-103E2	37.04	5.04	3.07	2.85	2.19	1.10	1.32	0.88	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	6.41	3.20	0.00	0.27	0.27	0.00	0.00	0.00	0.80